Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 11p15.5-15.4(chr11:61793-10727969)x3	DENND5A|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FAM99A|FAM99B|FHIP1B|GATD1|GATD1-DT|H19|H19-ICR|HBB|HBB-3'HS1|HBB-HS-107|HBB-HS-111|HBB-LCR|HBD|HBE1|HBG1|HBG2|HOTS|HPX|HRAS|HS-E1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IPO7|IRAG1|IRAG1-AS1|IRF7|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LINC01001|LINC01150|LINC01219|LINC02688|LINC02708|LINC02709|LINC02749|LMNTD2|LMNTD2-AS1|LMO1|LOC101927708|LOC101928008|LOC105274310|LOC105369149|LOC105376526|LOC106099062|LOC106099063|LOC106099064|LOC106099065|LOC106783508|LOC106799843|LOC106865369|LOC107133510|LOC109623489|LOC109951029|LOC110006319|LOC110008579|LOC110011217|LOC110013311|LOC110121378|LOC110121453|LOC111718490|LOC112067719|LOC112067720|LOC112081391|LOC112081400|LOC112081404|LOC112081405|LOC112136080|LOC112136081|LOC112136092|LOC112136094|LOC113939920|LOC113939924|LOC113939927|LOC113939928|LOC114827852|LOC116216126|LOC116216127|LOC116216128|LOC116216129|LOC121392887|LOC121392888|LOC121392889|LOC121392890|LOC121832782|LOC121832783|LOC121832784|LOC121832785|LOC121832786|LOC124418409|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC124418422|LOC124418423|LOC124418426|LOC124421482|LOC124421483|LOC124421484|LOC124421485|LOC124421486|LOC124902806|LOC126861108|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC126861117|LOC126861118|LOC126861119|LOC126861120|LOC126861121|LOC126861122|LOC126861123|LOC126861124|LOC126861125|LOC126861126|LOC126861127|LOC126861128|LOC126861129|LOC126861130|LOC126861131|LOC126861132|LOC126861133|LOC126861134|LOC126861135|LOC126861136|LOC126861137|LOC126861138|LOC126861139|LOC129388416|LOC129388417|LOC129390245|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC129390252|LOC129390253|LOC129390254|LOC129390255|LOC129390256|LOC129390257|LOC129390258|LOC130005037|LOC130005038|LOC130005039|LOC130005040|LOC130005041|LOC130005042|LOC130005043|LOC130005044|LOC130005045|LOC130005046|LOC130005047|LOC130005048|LOC130005049|LOC130005050|LOC130005051|LOC130005052|LOC130005053|LOC130005054|LOC130005055|LOC130005056|LOC130005057|LOC130005058|LOC130005059|LOC130005060|LOC130005061|LOC130005062|LOC130005063|LOC130005064|LOC130005065|LOC130005066|LOC130005067|LOC130005068|LOC130005069|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163|LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC130005179|LOC130005180|LOC130005181|LOC130005182|LOC130005183|LOC130005184|LOC130005185|LOC130005186|LOC130005187|LOC130005188|LOC130005189|LOC130005190|LOC130005191|LOC130005192|LOC130005193|LOC130005194|LOC130005195|LOC130005196|LOC130005197|LOC130005198|LOC130005199|LOC130005200|LOC130005201|LOC130005202|LOC130005203|LOC130005204|LOC130005205|LOC130005206|LOC130005207|LOC130005208|LOC130005209|LOC130005210|LOC130005211|LOC130005212|LOC130005213|LOC130005214|LOC130005215|LOC130005216|LOC130005217|LOC130005218|LOC130005219|LOC130005220|LOC130005221|LOC130005222|LOC130005223|LOC130005224|LOC130005225|LOC130005226|LOC130005227|LOC130005228|LOC130005229|LOC130005230|LOC130005231|LOC130005232|LOC130005233|LOC130005234|LOC130005235|LOC130005236|LOC130005237|LOC130005238|LOC130005239|LOC130005240|LOC130005241|LOC130005242|LOC130005243|LOC130005244|LOC130005245|LOC130005246|LOC130005247|LOC130005248|LOC130005249|LOC130005250|LOC130005251|LOC130005252|LOC130005253|LOC130005254|LOC130005255|LOC130005256|LOC130005257|LOC130005258|LOC130005259|LOC130005260|LOC130005261|LOC130005262|LOC130005263|LOC130005264|LOC130005265|LOC130005266|LOC130005267|LOC130005268|LOC130005269|LOC130005270|LOC130005271|LOC130005272|LOC130005273|LOC130005274|LOC130005275|LOC130005276|LOC130005277|LOC130005278|LOC130005279|LOC130005280|LOC130005281|LOC130005282|LOC130005283|LOC130005284|LOC130005285|LOC130005286|LOC130005287|LOC130005288|LOC130005289|LOC130005290|LOC130005291|LOC130005292|LOC130005293|LOC130005294|LOC130005295|LOC130005296|LOC130005297|LOC130005298|LOC130005299|LOC130005300|LOC130005301|LOC130005302|LOC130005303|LOC130005304|LOC130005305|LOC130005306|LOC130005307|LOC130005308|LOC130005309|LOC130005310|LOC130005311|LOC130005312|LOC130005313|LOC130005314|LOC130005315|LOC130005316|LOC130005317|LOC130005318|LOC130005319|LOC130005320|LOC130005321|LOC130005322|LOC130005323|LOC130005324|LOC130005325|LOC130005326|LOC130005327|LOC130005328|LOC130005329|LOC130005330|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC143666|LOC283299|LRRC56|LSP1|LYVE1|MIR210|MIR210HG|MIR302E|MIR4298|MIR4485|MIR4686|MIR4687|MIR483|MIR5691|MIR6743|MIR6744|MIR675|MIR7847|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRPL17|MRPL23|MRPL23-AS1|MTRNR2L8|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NRIP3|NRIP3-DT|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|A-GAMMA3'E|ADM|ADM-DT|AKIP1|AMPD3|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BET1L|BGLT3|BRSK2|C11orf16|C11orf21|C11orf40|C11orf42|CAND1.11|CARS1|CARS1-AS1|CASC23|CAVIN3|CCKBR|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DENND2B-AS1|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51C1P|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51J1|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E1|OR52E2|OR52E4|OR52E5|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52P1|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B2P|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PANO1|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PRADX|PRR33|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RIC3-DT|RIC8A|RNF141|RNH1|RPL27A|RPLP2|RRM1|RRP8|SBF2|SBF2-AS1|SCGB1C1|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA23|SNORA3A|SNORA3B|SNORA52|SNORA54|SNORD131|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|STK33|SWAP70|SYT8|SYT9|SYT9-AS1|TAF10|TALDO1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TMEM9B-AS1|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRL-CAA5-1|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|TUB-AS1|UBQLN3|UBQLNL|WEE1|ZNF143|ZNF143-AS1|ZNF195|ZNF214|ZNF215		See cases	VCV000151263	11	61793 - 10749516	11	61793 - 10727969	151263	161014			copy number gain		Pathogenic	Apr 30, 2011	no assertion criteria provided							
GRCh38/hg38 11p15.5-15.1(chr11:446754-18904742)x3	TRIM22|TRIM3|TUB-AS1|UBQLN3|TRIM34|TRIM5|UBQLNL|UEVLD|TRIM66|TRIM68|TRIM6|TSG101|TSPAN32|TSSC4|TUB|WEE1|ZBED5|ZBED5-AS1|ZNF143|ZNF143-AS1|USH1C|USP47|ZNF195|ZNF214|ZNF215|TPP1|TRIM21|TMEM9B|TMEM9B-AS1|TNNI2|TNNT3|TOLLIP|TOLLIP-DT|TPH1|TRL-CAA5-1|TRPM5|TSPAN4|A-GAMMA3'E|ABCC8|ADM|ADM-DT|AKIP1|AMPD3|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|BGLT3|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CAND1.11|CARS1|CARS1-AS1|CASC23|CAVIN3|CCKBR|CD151|CD81|CD81-AS1|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CTR9|CTSD|CYB5R2|CYP2R1|DCHS1|DEAF1|DENND2B|DENND2B-AS1|DENND5A|DKK3|DNHD1|DRD4|DUSP8|EIF3F|EIF4G2|EPS8L2|FAM99A|FAM99B|FAR1|FHIP1B|GALNT18|GATD1|GATD1-DT|GTF2H1|H19|H19-ICR|HBB|HBB-3'HS1|HBB-HS-107|HBB-HS-111|HBB-LCR|HBD|HBE1|HBG1|HBG2|HOTS|HPS5|HPX|HRAS|HS-E1|IFITM10|IGF2|IGF2-AS|IGSF22|IGSF22-AS1|ILK|INS|INS-IGF2|INSC|IPO7|IRAG1|IRAG1-AS1|IRF7|KCNC1|KCNJ11|KCNQ1|KCNQ1-AS1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-AS1|LDHA|LDHAL6A|LDHC|LINC00958|LINC01150|LINC01219|LINC02545|LINC02547|LINC02548|LINC02682|LINC02683|LINC02688|LINC02708|LINC02709|LINC02729|LINC02749|LINC02751|LINC02752|LINC02989|LMNTD2|LMNTD2-AS1|LMO1|LOC101927708|LOC101928008|LOC101928053|LOC105274310|LOC105369149|LOC105376526|LOC106099062|LOC106099063|LOC106099064|LOC106099065|LOC106736470|LOC106783508|LOC106799843|LOC106865369|LOC107133510|LOC107988023|LOC108254681|LOC108281125|LOC109623489|LOC109951029|LOC110006319|LOC110008579|LOC110011217|LOC110013311|LOC110120848|LOC110120922|LOC110120926|LOC110120947|LOC110121340|LOC110121343|LOC110121378|LOC110121434|LOC110121453|LOC110121471|LOC110121483|LOC111413037|LOC111718490|LOC111982890|LOC112042781|LOC112042782|LOC112067712|LOC112067713|LOC112067714|LOC112067715|LOC112067716|LOC112067719|LOC112067720|LOC112081391|LOC112081400|LOC112081404|LOC112081405|LOC112136080|LOC112136081|LOC112136092|LOC112136094|LOC113939920|LOC113939924|LOC113939927|LOC113939928|LOC114827852|LOC116216127|LOC116216128|LOC116216129|LOC121392887|LOC121392888|LOC121392889|LOC121392890|LOC121392891|LOC121392892|LOC121832782|LOC121832783|LOC121832784|LOC121832785|LOC121832786|LOC121832787|LOC121832788|LOC124418411|LOC124418412|LOC124418413|LOC124418414|LOC124418415|LOC124418416|LOC124418418|LOC124418419|LOC124418420|LOC124418421|LOC124418422|LOC124418423|LOC124418426|LOC124421482|LOC124421483|LOC124421484|LOC124421485|LOC124421486|LOC124421487|LOC124421488|LOC124421489|LOC124421490|LOC124421491|LOC124421492|LOC124421493|LOC124421494|LOC124421495|LOC124421496|LOC124421497|LOC124421498|LOC124421499|LOC124421500|LOC124421501|LOC124421502|LOC124421503|LOC124902806|LOC126861109|LOC126861110|LOC126861111|LOC126861112|LOC126861113|LOC126861114|LOC126861115|LOC126861116|LOC126861117|LOC126861118|LOC126861119|LOC126861120|LOC126861121|LOC126861122|LOC126861123|LOC126861124|LOC126861125|LOC126861126|LOC126861127|LOC126861128|LOC126861129|LOC126861130|LOC126861131|LOC126861132|LOC126861133|LOC126861134|LOC126861135|LOC126861136|LOC126861137|LOC126861138|LOC126861139|LOC126861140|LOC126861141|LOC126861142|LOC126861143|LOC126861144|LOC126861145|LOC126861146|LOC126861147|LOC126861148|LOC126861149|LOC126861150|LOC126861151|LOC126861152|LOC126861153|LOC126861154|LOC128772342|LOC128772343|LOC128772344|LOC128772345|LOC128772346|LOC129388416|LOC129388417|LOC129390246|LOC129390247|LOC129390248|LOC129390249|LOC129390250|LOC129390251|LOC129390252|LOC129390253|LOC129390254|LOC129390255|LOC129390256|LOC129390257|LOC129390258|LOC129390259|LOC129390260|LOC129390261|LOC129390262|LOC129390263|LOC129390264|LOC129390265|LOC129390266|LOC129390267|LOC129390268|LOC129390269|LOC130005070|LOC130005071|LOC130005072|LOC130005073|LOC130005074|LOC130005075|LOC130005076|LOC130005077|LOC130005078|LOC130005079|LOC130005080|LOC130005081|LOC130005082|LOC130005083|LOC130005084|LOC130005085|LOC130005086|LOC130005087|LOC130005088|LOC130005089|LOC130005090|LOC130005091|LOC130005092|LOC130005093|LOC130005094|LOC130005095|LOC130005096|LOC130005097|LOC130005098|LOC130005099|LOC130005100|LOC130005101|LOC130005102|LOC130005103|LOC130005104|LOC130005105|LOC130005106|LOC130005107|LOC130005108|LOC130005109|LOC130005110|LOC130005111|LOC130005112|LOC130005113|LOC130005114|LOC130005115|LOC130005116|LOC130005117|LOC130005118|LOC130005119|LOC130005120|LOC130005121|LOC130005122|LOC130005123|LOC130005124|LOC130005125|LOC130005126|LOC130005127|LOC130005128|LOC130005129|LOC130005130|LOC130005131|LOC130005132|LOC130005133|LOC130005134|LOC130005135|LOC130005136|LOC130005137|LOC130005138|LOC130005139|LOC130005140|LOC130005141|LOC130005142|LOC130005143|LOC130005144|LOC130005145|LOC130005146|LOC130005147|LOC130005148|LOC130005149|LOC130005150|LOC130005151|LOC130005152|LOC130005153|LOC130005154|LOC130005155|LOC130005156|LOC130005157|LOC130005158|LOC130005159|LOC130005160|LOC130005161|LOC130005162|LOC130005163|LOC130005164|LOC130005165|LOC130005166|LOC130005167|LOC130005168|LOC130005169|LOC130005170|LOC130005171|LOC130005172|LOC130005173|LOC130005174|LOC130005175|LOC130005176|LOC130005177|LOC130005178|LOC130005179|LOC130005180|LOC130005181|LOC130005182|LOC130005183|LOC130005184|LOC130005185|LOC130005186|LOC130005187|LOC130005188|LOC130005189|LOC130005190|LOC130005191|LOC130005192|LOC130005193|LOC130005194|LOC130005195|LOC130005196|LOC130005197|LOC130005198|LOC130005199|LOC130005200|LOC130005201|LOC130005202|LOC130005203|LOC130005204|LOC130005205|LOC130005206|LOC130005207|LOC130005208|LOC130005209|LOC130005210|LOC130005211|LOC130005212|LOC130005213|LOC130005214|LOC130005215|LOC130005216|LOC130005217|LOC130005218|LOC130005219|LOC130005220|LOC130005221|LOC130005222|LOC130005223|LOC130005224|LOC130005225|LOC130005226|LOC130005227|LOC130005228|LOC130005229|LOC130005230|LOC130005231|LOC130005232|LOC130005233|LOC130005234|LOC130005235|LOC130005236|LOC130005237|LOC130005238|LOC130005239|LOC130005240|LOC130005241|LOC130005242|LOC130005243|LOC130005244|LOC130005245|LOC130005246|LOC130005247|LOC130005248|LOC130005249|LOC130005250|LOC130005251|LOC130005252|LOC130005253|LOC130005254|LOC130005255|LOC130005256|LOC130005257|LOC130005258|LOC130005259|LOC130005260|LOC130005261|LOC130005262|LOC130005263|LOC130005264|LOC130005265|LOC130005266|LOC130005267|LOC130005268|LOC130005269|LOC130005270|LOC130005271|LOC130005272|LOC130005273|LOC130005274|LOC130005275|LOC130005276|LOC130005277|LOC130005278|LOC130005279|LOC130005280|LOC130005281|LOC130005282|LOC130005283|LOC130005284|LOC130005285|LOC130005286|LOC130005287|LOC130005288|LOC130005289|LOC130005290|LOC130005291|LOC130005292|LOC130005293|LOC130005294|LOC130005295|LOC130005296|LOC130005297|LOC130005298|LOC130005299|LOC130005300|LOC130005301|LOC130005302|LOC130005303|LOC130005304|LOC130005305|LOC130005306|LOC130005307|LOC130005308|LOC130005309|LOC130005310|LOC130005311|LOC130005312|LOC130005313|LOC130005314|LOC130005315|LOC130005316|LOC130005317|LOC130005318|LOC130005319|LOC130005320|LOC130005321|LOC130005322|LOC130005323|LOC130005324|LOC130005325|LOC130005326|LOC130005327|LOC130005328|LOC130005329|LOC130005330|LOC130005331|LOC130005332|LOC130005333|LOC130005334|LOC130005335|LOC130005336|LOC130005337|LOC130005338|LOC130005339|LOC130005340|LOC130005341|LOC130005342|LOC130005343|LOC130005344|LOC130005345|LOC130005346|LOC130005347|LOC130005348|LOC130005349|LOC130005350|LOC130005351|LOC130005352|LOC130005353|LOC130005354|LOC130005355|LOC130005356|LOC130005357|LOC130005358|LOC130005359|LOC130005360|LOC130005361|LOC130005362|LOC130005363|LOC130005364|LOC130005365|LOC130005366|LOC130005367|LOC130005368|LOC130005369|LOC130005370|LOC130005371|LOC130005372|LOC130005373|LOC130005374|LOC130005375|LOC130005376|LOC130005377|LOC130005378|LOC130005379|LOC130005380|LOC130005381|LOC130005382|LOC130005383|LOC130005384|LOC130005385|LOC130005386|LOC130005387|LOC130005388|LOC130005389|LOC130005390|LOC130005391|LOC130005392|LOC130005393|LOC130005394|LOC130005395|LOC130005396|LOC130005397|LOC130005398|LOC130005399|LOC130005400|LOC130005401|LOC130005402|LOC130005403|LOC130005404|LOC130005405|LOC130005406|LOC130005407|LOC130005408|LOC130005409|LOC130005410|LOC130005411|LOC130005412|LOC130005413|LOC130005414|LOC130005415|LOC130005416|LOC130005417|LOC130005418|LOC130005419|LOC132089897|LOC132089898|LOC132089899|LOC132089927|LOC132089930|LOC132089931|LOC132090831|LOC132090832|LOC132090833|LOC143666|LOC283299|LRRC56|LSP1|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MIR302E|MIR3159|MIR4298|MIR4299|MIR4485|MIR4686|MIR4687|MIR483|MIR5691|MIR6073|MIR6124|MIR6744|MIR675|MIR7847|MIR8070|MISFA|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRG-AS1|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MRPL23-AS1|MTRNR2L8|MUC2|MUC5AC|MUC5B|MUC5B-AS1|MUC6|MYOD1|NAP1L4|NCR3LG1|NLRP10|NLRP14|NRIP3|NRIP3-DT|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51C1P|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51J1|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E1|OR52E2|OR52E4|OR52E5|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52P1|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B2P|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PANO1|PARVA|PDE3B|PGAP2|PHLDA2|PHRF1|PIDD1|PIK3C2A|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PRADX|PRR33|PSMA1|PTDSS2|PTH|PTPN5|RASSF10|RASSF10-DT|RASSF7|RBMXL2|RHOG|RIC3|RIC3-DT|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SBF2|SBF2-AS1|SCT|SCUBE2|SERGEF|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA23|SNORA3A|SNORA3B|SNORA52|SNORA54|SNORD131|SNORD147|SNORD14A|SNORD14B|SNORD97|SOX6|SPON1|SPTY2D1|SSU72L1|SSU72L2|SSU72L3|SSU72L4|SSU72L5|STIM1|STIM1-AS1|STK33|SWAP70|SYT8|SYT9|SYT9-AS1|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A		See cases	VCV000144515	11	446754 - 18926289	11	446754 - 18904742	144515	154266			copy number gain		Pathogenic	Apr 30, 2010	no assertion criteria provided							
GRCh38/hg38 11p15.4(chr11:6261582-6637999)x3	APBB1|ARFIP2|CAVIN3|CCKBR|DCHS1|DNHD1|HPX|ILK|LOC112081404|LOC112081405|LOC113939924|LOC124418422|LOC124418423|LOC126861124|LOC126861125|LOC130005189|LOC130005190|LOC130005191|LOC130005192|LOC130005193|LOC130005194|LOC130005195|LOC130005196|LOC130005197|LOC130005198|LOC130005199|LOC130005200|LOC130005201|LOC130005202|LOC130005203|LOC130005204|LOC130005205|LOC130005206|LOC130005207|LOC130005208|LOC130005209|LOC130005210|RRP8|SMPD1|TAF10|TIMM10B|TPP1|TRIM3		See cases	VCV000147641	11	6282812 - 6659230	11	6261582 - 6637999	147641	157392			copy number gain		Pathogenic	Jan 30, 2010	no assertion criteria provided							
NC_000011.10:g.6603573A>G	ILK|LOC130005199|RRP8		not provided	VCV001316407	11	6624803	11	6603573	1316407	1308809	rs117253476	NC_000011.10:6603572:A:G	single nucleotide variant	5 prime UTR variant	Likely benign	Oct 23, 2020	criteria provided, multiple submitters, no conflicts							
NC_000011.10:g.6603668G>A	ILK|LOC130005200		not provided	VCV001277514	11	6624898	11	6603668	1277514	1266094	rs2555180	NC_000011.10:6603667:G:A	single nucleotide variant		Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.-129G>T	ILK|LOC130005200		not provided	VCV000671499	11	6625016	11	6603786	671499	656073	rs11607058	NC_000011.10:6603785:G:T	single nucleotide variant	5 prime UTR variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.-113G>T	ILK|LOC130005200		not specified	VCV000383971	11	6625032	11	6603802	383971	371588	rs1057521804	NC_000011.10:6603801:G:T	single nucleotide variant	5 prime UTR variant	Likely benign	Feb 22, 2016	criteria provided, single submitter							
NM_004517.4(ILK):c.-109C>T	ILK|LOC130005200		not specified	VCV000385262	11	6625036	11	6603806	385262	372281	rs908902784	NC_000011.10:6603805:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Apr 1, 2016	criteria provided, single submitter							
NM_004517.4(ILK):c.-108T>C	ILK|LOC130005200		not specified	VCV000137589	11	6625037	11	6603807	137589	141292	rs139314477	NC_000011.10:6603806:T:C	single nucleotide variant	5 prime UTR variant	Benign	May 29, 2014	criteria provided, single submitter							
NM_004517.4(ILK):c.-105A>G	LOC130005200|ILK		not specified	VCV000381219	11	6625040	11	6603810	381219	371590	rs373151075	NC_000011.10:6603809:A:G	single nucleotide variant	5 prime UTR variant	Likely benign	Nov 9, 2015	criteria provided, single submitter							
NM_004517.4(ILK):c.-93+150G>C	ILK		not provided	VCV001318053	11	6625202	11	6603972	1318053	1309147	rs2555178	NC_000011.10:6603971:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jul 11, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.-92-95A>G	ILK		not provided	VCV001317845	11	6625315	11	6604085	1317845	1308939	rs2659861	NC_000011.10:6604084:A:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jul 11, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.-92-39A>G	ILK		not provided	VCV000675791	11	6625371	11	6604141	675791	665112	rs143318774	NC_000011.10:6604140:A:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.-16G>A	ILK|LOC130005201		not specified	VCV000509417	11	6625486	11	6604256	509417	504301	rs1554896788	NC_000011.10:6604255:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	May 8, 2017	criteria provided, single submitter							
NM_004517.4(ILK):c.7G>C (p.Asp3His)	ILK|LOC130005201	D3H	Primary familial hypertrophic cardiomyopathy	VCV000854224	11	6625508	11	6604278	854224	838776	rs1342682020	NC_000011.10:6604277:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 25, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.12T>A (p.Ile4=)	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy|not specified	VCV000386645	11	6625513	11	6604283	386645	371596	rs747409130	NC_000011.10:6604282:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.15C>T (p.Phe5=)	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy	VCV001928413	11	6625516	11	6604286	1928413	1991180		NC_000011.10:6604285:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.21G>A (p.Gln7=)	ILK|LOC130005201		not specified	VCV002451637	11	6625522	11	6604292	2451637	2429941		NC_000011.10:6604291:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jan 13, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.35A>G (p.Asn12Ser)	ILK|LOC130005201	N12S	Primary familial hypertrophic cardiomyopathy	VCV001055841	11	6625536	11	6604306	1055841	1047389	rs765978022	NC_000011.10:6604305:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 18, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.36C>T (p.Asn12=)	LOC130005201|ILK		not specified|Primary familial hypertrophic cardiomyopathy	VCV000463183	11	6625537	11	6604307	463183	461535	rs199789449	NC_000011.10:6604306:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Dec 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.39A>G (p.Ala13=)	ILK|LOC130005201		not specified	VCV003528909	11	6625540	11	6604310	3528909	3686644		NC_000011.10:6604309:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.42C>T (p.Val14=)	LOC130005201|ILK		not specified	VCV003528908	11	6625543	11	6604313	3528908	3686643		NC_000011.10:6604312:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.45C>G (p.Ala15=)	ILK|LOC130005201		not specified	VCV003528910	11	6625546	11	6604316	3528910	3686645		NC_000011.10:6604315:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.46G>T (p.Val16Phe)	ILK|LOC130005201	V16F	not specified	VCV003109498	11	6625547	11	6604317	3109498	3271304		NC_000011.10:6604316:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 17, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.48T>C (p.Val16=)	ILK|LOC130005201		not specified	VCV003528905	11	6625549	11	6604319	3528905	3686640		NC_000011.10:6604318:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.52C>T (p.Leu18=)	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy|not specified	VCV001746694	11	6625553	11	6604323	1746694	1806240		NC_000011.10:6604322:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.63C>T (p.Asp21=)	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy|not specified	VCV001753307	11	6625564	11	6604334	1753307	1811631		NC_000011.10:6604333:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Apr 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.65A>G (p.Asn22Ser)	ILK|LOC130005201	N22S	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not specified|not provided	VCV000201788	11	6625566	11	6604336	201788	198363	rs114115159	NC_000011.10:6604335:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Dec 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.67A>T (p.Thr23Ser)	ILK|LOC130005201	T23S	not specified	VCV002612639	11	6625568	11	6604338	2612639	2777263		NC_000011.10:6604337:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.69G>C (p.Thr23=)	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy	VCV001146904	11	6625570	11	6604340	1146904	1142576	rs780181986	NC_000011.10:6604339:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Dec 19, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.72G>A (p.Glu24=)	ILK|LOC130005201		not specified	VCV001758196	11	6625573	11	6604343	1758196	1822713		NC_000011.10:6604342:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Aug 12, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.78C>A (p.Asp26Glu)	ILK|LOC130005201	D26E	not specified	VCV002566097	11	6625579	11	6604349	2566097	2728882		NC_000011.10:6604348:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.79C>A (p.Leu27Ile)	LOC130005201|ILK	L27I	Primary familial hypertrophic cardiomyopathy	VCV001447650	11	6625580	11	6604350	1447650	1403537	rs2134516915	NC_000011.10:6604349:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 13, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.83A>G (p.Asn28Ser)	ILK|LOC130005201	N28S	Primary familial hypertrophic cardiomyopathy	VCV002826521	11	6625584	11	6604354	2826521	2989742		NC_000011.10:6604353:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.86dup (p.Asp31fs)	ILK|LOC130005201	D31fs	Primary familial hypertrophic cardiomyopathy	VCV000155798	11	6625586 - 6625587	11	6604356 - 6604357	155798	165550	rs587782950	NC_000011.10:6604356:A:AA	Duplication	frameshift variant|5 prime UTR variant	Uncertain significance	Nov 19, 2013	no assertion criteria provided							
NM_004517.4(ILK):c.89+3G>A	ILK|LOC130005201		not provided	VCV000386910	11	6625593	11	6604363	386910	372507	rs1057522639	NC_000011.10:6604362:G:A	single nucleotide variant	intron variant	Likely benign	Sep 13, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.89+6C>T	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy	VCV001054607	11	6625596	11	6604366	1054607	1047390	rs2134517158	NC_000011.10:6604365:C:T	single nucleotide variant	intron variant	Uncertain significance	Mar 19, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.89+8G>T	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy	VCV002869364	11	6625598	11	6604368	2869364	3027847		NC_000011.10:6604367:G:T	single nucleotide variant	intron variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.89+13G>A	ILK|LOC130005201		Primary familial hypertrophic cardiomyopathy	VCV001667507	11	6625603	11	6604373	1667507	1656791	rs1056145541	NC_000011.10:6604372:G:A	single nucleotide variant	intron variant	Likely benign	Mar 18, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.90-234G>A	ILK|TAF10		not provided	VCV001287701	11	6629042	11	6607812	1287701	1277533	rs2255538	NC_000011.10:6607811:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.90-17T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001601475	11	6629259	11	6608029	1601475	1523421	rs372812947	NC_000011.10:6608028:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jul 28, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.90-5C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000698782	11	6629271	11	6608041	698782	690008	rs201421009	NC_000011.10:6608040:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jun 13, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.93C>T (p.Asp31=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000697187	11	6629279	11	6608049	697187	684264	rs56057203	NC_000011.10:6608048:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.94G>A (p.Asp32Asn)	ILK|TAF10	D32N	not specified	VCV001767174	11	6629280	11	6608050	1767174	1821516		NC_000011.10:6608049:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.98A>C (p.His33Pro)	ILK|TAF10	H33P	not specified	VCV001768532	11	6629284	11	6608054	1768532	1828941		NC_000011.10:6608053:A:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 11, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.110C>T (p.Pro37Leu)	ILK|TAF10	P37L	Primary familial hypertrophic cardiomyopathy	VCV001413619	11	6629296	11	6608066	1413619	1361522	rs2134551114	NC_000011.10:6608065:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.111C>A (p.Pro37=)	TAF10|ILK		Primary familial hypertrophic cardiomyopathy|not specified	VCV001797173	11	6629297	11	6608067	1797173	1855747		NC_000011.10:6608066:C:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jun 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.111C>T (p.Pro37=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001572146	11	6629297	11	6608067	1572146	1538215	rs1444626441	NC_000011.10:6608066:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jul 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.117C>T (p.His39=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001156397	11	6629303	11	6608073	1156397	1142577	rs903002123	NC_000011.10:6608072:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.127C>G (p.Arg43Gly)	ILK|TAF10	R43G	not specified	VCV002451638	11	6629313	11	6608083	2451638	2429942		NC_000011.10:6608082:C:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.128G>A (p.Arg43Gln)	ILK|TAF10	R43Q	Primary familial hypertrophic cardiomyopathy	VCV001401337	11	6629314	11	6608084	1401337	1379324	rs768217957	NC_000011.10:6608083:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.130G>C (p.Glu44Gln)	TAF10|ILK	E44Q	Primary familial hypertrophic cardiomyopathy|not provided|ILK-related disorder	VCV000432422	11	6629316	11	6608086	432422	425939	rs145039481	NC_000011.10:6608085:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.132G>A (p.Glu44=)	ILK|TAF10		not specified	VCV003528907	11	6629318	11	6608088	3528907	3686642		NC_000011.10:6608087:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.136C>T (p.Arg46Cys)	ILK|TAF10	R46C	Primary familial hypertrophic cardiomyopathy|not specified	VCV001771012	11	6629322	11	6608092	1771012	1836150		NC_000011.10:6608091:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jul 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.137G>A (p.Arg46His)	ILK|TAF10	R46H	Primary familial hypertrophic cardiomyopathy	VCV001381022	11	6629323	11	6608093	1381022	1499865	rs370736279	NC_000011.10:6608092:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.138C>A (p.Arg46=)	ILK|TAF10		not specified	VCV003528902	11	6629324	11	6608094	3528902	3686637		NC_000011.10:6608093:C:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.140C>G (p.Ser47Cys)	ILK|TAF10	S47C	Primary familial hypertrophic cardiomyopathy|not specified	VCV001771983	11	6629326	11	6608096	1771983	1829795		NC_000011.10:6608095:C:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Apr 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.146T>C (p.Val49Ala)	ILK|TAF10	V49A	not provided|Primary familial hypertrophic cardiomyopathy	VCV000432620	11	6629332	11	6608102	432620	425940	rs201499797	NC_000011.10:6608101:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Mar 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.149T>C (p.Val50Ala)	ILK|TAF10	V50A	Primary familial hypertrophic cardiomyopathy|not specified	VCV001773967	11	6629335	11	6608105	1773967	1827073		NC_000011.10:6608104:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.151G>C (p.Glu51Gln)	ILK|TAF10	E51Q	Primary familial hypertrophic cardiomyopathy	VCV002724874	11	6629337	11	6608107	2724874	2885366		NC_000011.10:6608106:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.154A>G (p.Met52Val)	ILK|TAF10	M52V	not specified	VCV003528916	11	6629340	11	6608110	3528916	3686651		NC_000011.10:6608109:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 12, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.157T>C (p.Leu53=)	ILK|TAF10		not specified	VCV003528903	11	6629343	11	6608113	3528903	3686638		NC_000011.10:6608112:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.157T>A (p.Leu53Met)	ILK|TAF10	L53M	not provided|Primary familial hypertrophic cardiomyopathy	VCV000180371	11	6629343	11	6608113	180371	178647	rs200336608	NC_000011.10:6608112:T:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.164_181del (p.Met55_Ile60del)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000662408	11	6629345 - 6629362	11	6608115 - 6608132	662408	640336	rs746571606	NC_000011.10:6608114:GATCATGCGGGGGGCACGGATCA:GATCA	Deletion	inframe_deletion|3 prime UTR variant|intron variant	Uncertain significance	Oct 9, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.163A>G (p.Met55Val)	ILK|TAF10	M55V	Primary familial hypertrophic cardiomyopathy	VCV000849595	11	6629349	11	6608119	849595	838777	rs781296730	NC_000011.10:6608118:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.169G>A (p.Gly57Arg)	ILK|TAF10	G57R	Primary familial hypertrophic cardiomyopathy	VCV000862681	11	6629355	11	6608125	862681	838778	rs778110752	NC_000011.10:6608124:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Mar 28, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.171G>A (p.Gly57=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001107126	11	6629357	11	6608127	1107126	1100247	rs199880663	NC_000011.10:6608126:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.173C>T (p.Ala58Val)	ILK|TAF10	A58V	not specified	VCV003224305	11	6629359	11	6608129	3224305	3390110		NC_000011.10:6608128:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.175C>G (p.Arg59Gly)	ILK|TAF10	R59G	Primary familial hypertrophic cardiomyopathy	VCV001015492	11	6629361	11	6608131	1015492	1009846	rs779428507	NC_000011.10:6608130:C:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 8, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.175C>T (p.Arg59Trp)	TAF10|ILK	R59W	not provided|Primary familial hypertrophic cardiomyopathy	VCV000201789	11	6629361	11	6608131	201789	198364	rs779428507	NC_000011.10:6608130:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.177G>A (p.Arg59=)	ILK|TAF10		not specified	VCV003528906	11	6629363	11	6608133	3528906	3686641		NC_000011.10:6608132:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.183T>C (p.Asn61=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000761590	11	6629369	11	6608139	761590	768613	rs1420119164	NC_000011.10:6608138:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jan 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.184G>A (p.Val62Ile)	TAF10|ILK	V62I	Primary familial hypertrophic cardiomyopathy|not provided|not specified	VCV000201790	11	6629370	11	6608140	201790	198365	rs768146142	NC_000011.10:6608139:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.186A>G (p.Val62=)	ILK|TAF10		not specified	VCV003528904	11	6629372	11	6608142	3528904	3686639		NC_000011.10:6608141:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.186A>C (p.Val62=)	ILK|TAF10		not specified	VCV003224306	11	6629372	11	6608142	3224306	3390111		NC_000011.10:6608141:A:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Nov 1, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.193C>T (p.Arg65Cys)	ILK|TAF10	R65C	Primary familial hypertrophic cardiomyopathy	VCV000842920	11	6629379	11	6608149	842920	838779	rs776161614	NC_000011.10:6608148:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jan 27, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.199G>A (p.Asp67Asn)	ILK|TAF10	D67N	not specified	VCV003224307	11	6629385	11	6608155	3224307	3390112		NC_000011.10:6608154:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.205A>T (p.Thr69Ser)	ILK|TAF10	T69S	not specified	VCV001785188	11	6629391	11	6608161	1785188	1839985		NC_000011.10:6608160:A:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jul 12, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.206C>T (p.Thr69Ile)	ILK|TAF10	T69I	Primary familial hypertrophic cardiomyopathy	VCV000463181	11	6629392	11	6608162	463181	461366	rs763031937	NC_000011.10:6608161:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.211del (p.Leu71fs)	TAF10|ILK	L71fs	not specified	VCV000208590	11	6629392	11	6608162	208590	205169	rs776120061	NC_000011.10:6608161:CCCCCC:CCCCC	Deletion	frameshift variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 11, 2016	criteria provided, single submitter							
NM_004517.4(ILK):c.207C>G (p.Thr69=)	ILK|TAF10		not specified	VCV001785526	11	6629393	11	6608163	1785526	1840323		NC_000011.10:6608162:C:G	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Aug 5, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.207C>T (p.Thr69=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001153984	11	6629393	11	6608163	1153984	1142578	rs751471922	NC_000011.10:6608162:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Nov 14, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.213G>A (p.Leu71=)	ILK|TAF10		not specified	VCV001786557	11	6629399	11	6608169	1786557	1843927		NC_000011.10:6608168:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Aug 10, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.219G>C (p.Leu73=)	ILK|TAF10		not specified	VCV000381754	11	6629405	11	6608175	381754	372285	rs1057521161	NC_000011.10:6608174:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Nov 11, 2015	criteria provided, single submitter							
NM_004517.4(ILK):c.222A>T (p.Ala74=)	ILK|TAF10		not specified	VCV000515649	11	6629408	11	6608178	515649	504305	rs1554898398	NC_000011.10:6608177:A:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Feb 21, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.223G>C (p.Ala75Pro)	ILK|TAF10	A75P	Primary familial hypertrophic cardiomyopathy	VCV000569806	11	6629409	11	6608179	569806	567459	rs1564845235	NC_000011.10:6608178:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Apr 6, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.230A>G (p.His77Arg)	ILK|TAF10	H77R	not specified	VCV001789403	11	6629416	11	6608186	1789403	1851073		NC_000011.10:6608185:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.231T>C (p.His77=)	ILK|TAF10		not provided|not specified|Primary familial hypertrophic cardiomyopathy	VCV001587685	11	6629417	11	6608187	1587685	1595336	rs757605280	NC_000011.10:6608186:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Dec 15, 2020	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.234A>G (p.Gly78=)	ILK|TAF10		not specified|not provided|Primary familial hypertrophic cardiomyopathy	VCV000668148	11	6629420	11	6608190	668148	656074	rs376885008	NC_000011.10:6608189:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.236A>T (p.His79Leu)	ILK|TAF10	H79L	Primary familial hypertrophic cardiomyopathy	VCV000656354	11	6629422	11	6608192	656354	640337	rs1589934860	NC_000011.10:6608191:A:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 20, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.238C>T (p.Arg80Cys)	ILK|TAF10	R80C	Primary familial hypertrophic cardiomyopathy|not specified	VCV002147915	11	6629424	11	6608194	2147915	1877227		NC_000011.10:6608193:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.244A>G (p.Ile82Val)	ILK|TAF10	I82V	Primary familial hypertrophic cardiomyopathy	VCV002771515	11	6629430	11	6608200	2771515	2933530		NC_000011.10:6608199:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.252_255+9dup	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002813165	11	6629432 - 6629433	11	6608202 - 6608203	2813165	2972967		NC_000011.10:6608202:GTACAGAAGGTACGTACA:GTACAGAAGGTACGTACAGAAGGTACGTACA	Duplication	3 prime UTR variant|splice donor variant|intron variant	Uncertain significance	Dec 5, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.246T>A (p.Ile82=)	ILK|TAF10		not specified	VCV001791766	11	6629432	11	6608202	1791766	1845199		NC_000011.10:6608201:T:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Nov 16, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.252G>A (p.Gln84=)	ILK|TAF10		not provided|Primary familial hypertrophic cardiomyopathy|not specified	VCV000227442	11	6629438	11	6608208	227442	230222	rs757818130	NC_000011.10:6608207:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Dec 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.255+3A>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000862792	11	6629444	11	6608214	862792	851902	rs1440217863	NC_000011.10:6608213:A:G	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.255+4C>T	TAF10|ILK		not provided|Primary familial hypertrophic cardiomyopathy	VCV000389142	11	6629445	11	6608215	389142	372288	rs371539613	NC_000011.10:6608214:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.255+10A>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided	VCV000386494	11	6629451	11	6608221	386494	372519	rs757579795	NC_000011.10:6608220:A:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 27, 2020	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.255+17T>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002718550	11	6629458	11	6608228	2718550	2876946		NC_000011.10:6608227:T:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Apr 1, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.255+19G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001395499	11	6629460	11	6608230	1395499	1424898	rs201214821	NC_000011.10:6608229:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.255+89G>A	TAF10|ILK		not provided	VCV000672699	11	6629530	11	6608300	672699	665764	rs2048092	NC_000011.10:6608299:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.256-7G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001034721	11	6629617	11	6608387	1034721	1030405	rs1405710988	NC_000011.10:6608386:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	May 20, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.261G>A (p.Leu87=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV002078496	11	6629629	11	6608399	2078496	2135026		NC_000011.10:6608398:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant	Likely benign	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.264G>C (p.Gln88His)	ILK|TAF10	Q88H	Primary familial hypertrophic cardiomyopathy	VCV001963317	11	6629632	11	6608402	1963317	2016989		NC_000011.10:6608401:G:C	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.266A>C (p.Tyr89Ser)	ILK|TAF10	Y89S	Primary familial hypertrophic cardiomyopathy	VCV001980908	11	6629634	11	6608404	1980908	2034978		NC_000011.10:6608403:A:C	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant	Uncertain significance	Apr 30, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.274G>A (p.Asp92Asn)	ILK|TAF10	D92N	Primary familial hypertrophic cardiomyopathy	VCV002013818	11	6629642	11	6608412	2013818	2067901		NC_000011.10:6608411:G:A	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant	Uncertain significance	Aug 13, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.277A>G (p.Ile93Val)	ILK|TAF10	I93V	Primary familial hypertrophic cardiomyopathy|not provided|not specified	VCV000418259	11	6629645	11	6608415	418259	408424	rs777569798	NC_000011.10:6608414:A:G	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant	Uncertain significance	Mar 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.279C>A (p.Ile93=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000382017	11	6629647	11	6608417	382017	372294	rs565996441	NC_000011.10:6608416:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant	Likely benign	Dec 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.282T>C (p.Asn94=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided|not specified	VCV000379141	11	6629650	11	6608420	379141	374182	rs143552228	NC_000011.10:6608419:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant	Benign/Likely benign	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.288G>A (p.Val96=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001646085	11	6629656	11	6608426	1646085	1565689	rs148059090	NC_000011.10:6608425:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant	Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.296A>C (p.His99Pro)	ILK|TAF10	H99P	Primary familial hypertrophic cardiomyopathy	VCV000942211	11	6629664	11	6608434	942211	935693	rs1173338186	NC_000011.10:6608433:A:C	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant	Uncertain significance	Sep 10, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.297C>T (p.His99=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided|not specified	VCV000137588	11	6629665	11	6608435	137588	141291	rs1043388	NC_000011.10:6608434:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.337G>T (p.Asp113Tyr)	ILK|TAF10	D113Y	Primary familial hypertrophic cardiomyopathy	VCV000463182	11	6629705	11	6608475	463182	461893	rs764104201	NC_000011.10:6608474:G:T	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.351+10C>T	TAF10|ILK		Primary familial hypertrophic cardiomyopathy|not specified	VCV000385263	11	6629729	11	6608499	385263	371599	rs781209717	NC_000011.10:6608498:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.351+18A>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001637758	11	6629737	11	6608507	1637758	1645351	rs1663195410	NC_000011.10:6608506:A:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 20, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.351+19A>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV000387190	11	6629738	11	6608508	387190	374185	rs183392482	NC_000011.10:6608507:A:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.351+39G>A	ILK|TAF10		not provided	VCV000673644	11	6629758	11	6608528	673644	666108	rs80013891	NC_000011.10:6608527:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jun 19, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.352-9T>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000698649	11	6629915	11	6608685	698649	690009	rs372657109	NC_000011.10:6608684:T:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Feb 3, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.352-8C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001664109	11	6629916	11	6608686	1664109	1654278	rs2134557160	NC_000011.10:6608685:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jun 2, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.352-4C>G	ILK|TAF10		not provided	VCV001316982	11	6629920	11	6608690	1316982	1306800	rs1434508206	NC_000011.10:6608689:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	May 20, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.352G>A (p.Asp118Asn)	TAF10|ILK	D118N	Primary familial hypertrophic cardiomyopathy	VCV001416430	11	6629924	11	6608694	1416430	1383252	rs2134557218	NC_000011.10:6608693:G:A	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.354C>T (p.Asp118=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002149099	11	6629926	11	6608696	2149099	1877547		NC_000011.10:6608695:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant|intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.364A>T (p.Asn122Tyr)	TAF10|ILK	N122Y	Primary familial hypertrophic cardiomyopathy|not specified	VCV001733583	11	6629936	11	6608706	1733583	1793204		NC_000011.10:6608705:A:T	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.370G>T (p.Ala124Ser)	ILK|TAF10	A124S	Primary familial hypertrophic cardiomyopathy	VCV001364215	11	6629942	11	6608712	1364215	1386154	rs745709169	NC_000011.10:6608711:G:T	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.373C>G (p.Leu125Val)	ILK|TAF10	L125V	Primary familial hypertrophic cardiomyopathy|not specified	VCV001498897	11	6629945	11	6608715	1498897	1488644	rs1305586718	NC_000011.10:6608714:C:G	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.377T>C (p.Val126Ala)	ILK|TAF10	V126A	Primary familial hypertrophic cardiomyopathy	VCV002150592	11	6629949	11	6608719	2150592	1891970		NC_000011.10:6608718:T:C	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.386G>C (p.Cys129Ser)	ILK|TAF10	C129S	not provided	VCV000635243	11	6629958	11	6608728	635243	623069	rs1332744590	NC_000011.10:6608727:G:C	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 11, 2015	no assertion criteria provided							
NM_004517.4(ILK):c.387T>C (p.Cys129=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001542427	11	6629959	11	6608729	1542427	1609964	rs1049786548	NC_000011.10:6608728:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant|intron variant	Likely benign	Aug 4, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.394T>G (p.Tyr132Asp)	TAF10|ILK	Y132D	Primary familial hypertrophic cardiomyopathy|not specified	VCV001736434	11	6629966	11	6608736	1736434	1796967		NC_000011.10:6608735:T:G	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.395A>G (p.Tyr132Cys)	ILK|TAF10	Y132C	Primary familial hypertrophic cardiomyopathy	VCV001513609	11	6629967	11	6608737	1513609	1468798	rs776660725	NC_000011.10:6608736:A:G	single nucleotide variant	missense variant|5 prime UTR variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 13, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.399A>G (p.Gly133=)	ILK|TAF10		not specified	VCV002566099	11	6629971	11	6608741	2566099	2728884		NC_000011.10:6608740:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|3 prime UTR variant|intron variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.410T>C (p.Val137Ala)	ILK|TAF10	V137A, V3A	Primary familial hypertrophic cardiomyopathy|not specified	VCV002428206	11	6629982	11	6608752	2428206	1951244		NC_000011.10:6608751:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.422A>G (p.Lys141Arg)	ILK|TAF10	K141R, K7R	Primary familial hypertrophic cardiomyopathy|not specified	VCV001438063	11	6629994	11	6608764	1438063	1510800	rs187795252	NC_000011.10:6608763:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	May 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.427C>A (p.Pro143Thr)	ILK|TAF10	P143T, P9T	Primary familial hypertrophic cardiomyopathy|not specified	VCV001739322	11	6629999	11	6608769	1739322	1797692		NC_000011.10:6608768:C:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.428C>T (p.Pro143Leu)	ILK|TAF10	P9L, P143L	Primary familial hypertrophic cardiomyopathy	VCV000860039	11	6630000	11	6608770	860039	838780	rs201763536	NC_000011.10:6608769:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.432G>A (p.Leu144=)	ILK|TAF10		not specified	VCV001739768	11	6630004	11	6608774	1739768	1794214		NC_000011.10:6608773:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Sep 13, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.435A>C (p.Arg145Ser)	TAF10|ILK	R145S, R11S	Primary familial hypertrophic cardiomyopathy|not specified	VCV000201785	11	6630007	11	6608777	201785	198366	rs139640491	NC_000011.10:6608776:A:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.436G>C (p.Glu146Gln)	ILK|TAF10	E146Q, E12Q	Primary familial hypertrophic cardiomyopathy	VCV001422987	11	6630008	11	6608778	1422987	1412880	rs2134557984	NC_000011.10:6608777:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 12, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.439C>T (p.Leu147Phe)	ILK|TAF10	L13F, L147F	not specified	VCV003285935	11	6630011	11	6608781	3285935	3444675		NC_000011.10:6608780:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.440T>C (p.Leu147Pro)	ILK|TAF10	L147P, L13P	not specified	VCV002473969	11	6630012	11	6608782	2473969	2446151		NC_000011.10:6608781:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jan 6, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.441T>G (p.Leu147=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV003285937	11	6630013	11	6608783	3285937	3444677		NC_000011.10:6608782:T:G	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.446G>A (p.Arg149Gln)	ILK|TAF10	R149Q, R15Q	Primary familial hypertrophic cardiomyopathy|not provided|not specified|Long QT syndrome	VCV000222652	11	6630018	11	6608788	222652	224434	rs869025437	NC_000011.10:6608787:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.448+4dup	TAF10|ILK		Primary familial hypertrophic cardiomyopathy	VCV002812211	11	6630022 - 6630023	11	6608792 - 6608793	2812211	2965604		NC_000011.10:6608792:CC:CCC	Duplication	3 prime UTR variant|intron variant	Uncertain significance	Dec 8, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.448+9=	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001166101	11	6630030 - 6630033	11	6608799 - 6608802	1166101	1156794		NC_000011.10:6608798:CCCC:CCCC	Variation	no sequence alteration|intron variant	Benign	Feb 1, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.448+12del	ILK|TAF10		not specified	VCV000201786	11	6630029	11	6608799	201786	198367	rs11314683	NC_000011.10:6608798:CCCC:CCC	Deletion	3 prime UTR variant|intron variant	Benign	Mar 6, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.448+11C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001625769	11	6630032	11	6608801	1625769	1607329	rs1855196418	NC_000011.10:6608800:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.449-15_449-12del	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002195117	11	6630098 - 6630101	11	6608867 - 6608870	2195117	1929484		NC_000011.10:6608866:TTGTTT:TT	Deletion	3 prime UTR variant|intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.449-15G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001612706	11	6630100	11	6608869	1612706	1601789	rs368896352	NC_000011.10:6608868:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Aug 13, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.449-11T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001631753	11	6630104	11	6608873	1631753	1597555	rs1465056090	NC_000011.10:6608872:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jul 6, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.449-3T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002020667	11	6630112	11	6608881	2020667	2079851		NC_000011.10:6608880:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.451C>T (p.Arg151Trp)	ILK|TAF10	R151W, R17W	Primary familial hypertrophic cardiomyopathy|not specified	VCV000966619	11	6630117	11	6608886	966619	956589	rs771485363	NC_000011.10:6608885:C:T	single nucleotide variant	missense variant|synonymous variant|3 prime UTR variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.452G>A (p.Arg151Gln)	ILK|TAF10	G119R, R17Q, R151Q	Primary familial hypertrophic cardiomyopathy	VCV000850465	11	6630118	11	6608887	850465	838781	rs774837228	NC_000011.10:6608886:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.458A>G (p.Glu153Gly)	ILK|TAF10	E153G, E19G, R121G	not provided	VCV000449611	11	6630124	11	6608893	449611	444861	rs867451051	NC_000011.10:6608892:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 10, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.466G>A (p.Gly156Ser)	ILK|TAF10	G22S, G156S, W123*	not specified|Primary familial hypertrophic cardiomyopathy	VCV000666077	11	6630132	11	6608901	666077	640338	rs199790448	NC_000011.10:6608900:G:A	single nucleotide variant	missense variant|nonsense|3 prime UTR variant	Conflicting classifications of pathogenicity	Dec 22, 2023	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.468C>A (p.Gly156=)	ILK|TAF10	A124D	not specified|Primary familial hypertrophic cardiomyopathy	VCV000532035	11	6630134	11	6608903	532035	526937	rs775797550	NC_000011.10:6608902:C:A	single nucleotide variant	synonymous variant|missense variant|3 prime UTR variant	Likely benign	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.472A>T (p.Asn158Tyr)	ILK|TAF10	N158Y, N24Y, R125S	not specified	VCV003224308	11	6630138	11	6608907	3224308	3390113		NC_000011.10:6608906:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.475C>G (p.Leu159Val)	ILK|TAF10	I126M, L25V, L159V	Primary familial hypertrophic cardiomyopathy|not specified	VCV001742882	11	6630141	11	6608910	1742882	1808963		NC_000011.10:6608909:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.478A>G (p.Asn160Asp)	ILK|TAF10	N160D, N26D	not specified	VCV001743083	11	6630144	11	6608913	1743083	1809164		NC_000011.10:6608912:A:G	single nucleotide variant	missense variant|synonymous variant|3 prime UTR variant	Uncertain significance	Dec 23, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.481C>T (p.Arg161Cys)	ILK|TAF10	R27C, R161C	not specified|Primary familial hypertrophic cardiomyopathy	VCV001402311	11	6630147	11	6608916	1402311	1454121	rs761400440	NC_000011.10:6608915:C:T	single nucleotide variant	missense variant|synonymous variant|3 prime UTR variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.482G>A (p.Arg161His)	ILK|TAF10	R161H, V129I, R27H	Primary familial hypertrophic cardiomyopathy|not specified	VCV001743415	11	6630148	11	6608917	1743415	1805561		NC_000011.10:6608916:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.489A>G (p.Pro163=)	ILK|TAF10	H131R	Primary familial hypertrophic cardiomyopathy	VCV002981798	11	6630155	11	6608924	2981798	3152453		NC_000011.10:6608923:A:G	single nucleotide variant	synonymous variant|missense variant|3 prime UTR variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.493A>G (p.Lys165Glu)	ILK|TAF10	K165E, K31E	not specified	VCV001744249	11	6630159	11	6608928	1744249	1799145		NC_000011.10:6608927:A:G	single nucleotide variant	missense variant|synonymous variant|3 prime UTR variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.501A>G (p.Thr167=)	ILK|TAF10	H135R	Primary familial hypertrophic cardiomyopathy|not specified	VCV000766562	11	6630167	11	6608936	766562	768614	rs1446758399	NC_000011.10:6608935:A:G	single nucleotide variant	synonymous variant|missense variant|3 prime UTR variant	Likely benign	Aug 25, 2020	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.503T>G (p.Phe168Cys)	TAF10|ILK	F168C, F34C, S136A	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	VCV000520261	11	6630169	11	6608938	520261	510336	rs747974626	NC_000011.10:6608937:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Oct 18, 2023	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.504C>G (p.Phe168Leu)	ILK|TAF10	F168L, F34L, S136C	Primary familial hypertrophic cardiomyopathy	VCV000532034	11	6630170	11	6608939	532034	526700	rs1554898796	NC_000011.10:6608938:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 12, 2017	criteria provided, single submitter							
NM_004517.4(ILK):c.513G>T (p.Gly171=)	ILK|TAF10	G139V	not specified	VCV002586351	11	6630179	11	6608948	2586351	2760485		NC_000011.10:6608947:G:T	single nucleotide variant	synonymous variant|missense variant|3 prime UTR variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.515C>T (p.Thr172Ile)	ILK|TAF10	T172I, P140S, T38I	not specified	VCV003528894	11	6630181	11	6608950	3528894	3686629		NC_000011.10:6608949:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 10, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.515C>A (p.Thr172Asn)	ILK|TAF10	P140T, T38N, T172N	not specified	VCV001745708	11	6630181	11	6608950	1745708	1799308		NC_000011.10:6608949:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 12, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.518C>T (p.Thr173Ile)	ILK|TAF10	P141S, T173I, T39I	Primary familial hypertrophic cardiomyopathy|not specified	VCV002154724	11	6630184	11	6608953	2154724	1885691		NC_000011.10:6608952:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.520C>T (p.Arg174Cys)	ILK|TAF10	R174C, R40C	not provided|Primary familial hypertrophic cardiomyopathy	VCV001948698	11	6630186	11	6608955	1948698	1996374		NC_000011.10:6608954:C:T	single nucleotide variant	missense variant|synonymous variant|3 prime UTR variant	Uncertain significance	Jan 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.521G>A (p.Arg174His)	ILK|TAF10	R174H, A142T, R40H	Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	VCV000520250	11	6630187	11	6608956	520250	510337	rs192233749	NC_000011.10:6608955:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.522C>T (p.Arg174=)	ILK|TAF10	A142V	Primary familial hypertrophic cardiomyopathy	VCV001114107	11	6630188	11	6608957	1114107	1100248	rs2134559961	NC_000011.10:6608956:C:T	single nucleotide variant	synonymous variant|missense variant|3 prime UTR variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.527G>A (p.Arg176Gln)	ILK|TAF10	R176Q, R42Q, G144S	Primary familial hypertrophic cardiomyopathy	VCV002723311	11	6630193	11	6608962	2723311	2885101		NC_000011.10:6608961:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.529C>T (p.Pro177Ser)	ILK|TAF10	P177S, P43S	Primary familial hypertrophic cardiomyopathy	VCV002744716	11	6630195	11	6608964	2744716	2901185		NC_000011.10:6608963:C:T	single nucleotide variant	missense variant|synonymous variant|3 prime UTR variant	Uncertain significance	Jul 24, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.532C>T (p.Arg178Ter)	ILK|TAF10	R44*, R178*	Primary familial hypertrophic cardiomyopathy	VCV001956157	11	6630198	11	6608967	1956157	2018878		NC_000011.10:6608966:C:T	single nucleotide variant	nonsense|synonymous variant|3 prime UTR variant	Uncertain significance	Jun 22, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.532+13T>C	TAF10|ILK		Primary familial hypertrophic cardiomyopathy	VCV002124280	11	6630211	11	6608980	2124280	2184742		NC_000011.10:6608979:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Apr 10, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.532+14G>A	ILK|TAF10		not specified	VCV000227443	11	6630212	11	6608981	227443	230223	rs776123992	NC_000011.10:6608980:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Mar 4, 2015	criteria provided, single submitter							
NM_004517.4(ILK):c.533-16C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002887400	11	6630286	11	6609055	2887400	3044105		NC_000011.10:6609054:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 27, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.533-14G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001571120	11	6630288	11	6609057	1571120	1646348	rs377346771	NC_000011.10:6609056:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.542C>T (p.Thr181Ile)	ILK|TAF10	T181I, T47I	Primary familial hypertrophic cardiomyopathy	VCV002724531	11	6630311	11	6609080	2724531	2888462		NC_000011.10:6609079:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.551A>C (p.Lys184Thr)	TAF10|ILK	K184T, K50T	not specified	VCV001174719	11	6630320	11	6609089	1174719	1164400	rs762454800	NC_000011.10:6609088:A:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Feb 11, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.555C>T (p.His185=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001126837	11	6630324	11	6609093	1126837	1121731	rs770369647	NC_000011.10:6609092:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.556T>C (p.Ser186Pro)	ILK|TAF10	S186P, S52P	not specified	VCV002242825	11	6630325	11	6609094	2242825	2233116		NC_000011.10:6609093:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 1, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.560G>T (p.Gly187Val)	ILK|TAF10	G53V, G187V	not specified	VCV002605078	11	6630329	11	6609098	2605078	2778746		NC_000011.10:6609097:G:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.567C>T (p.Asp189=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002917251	11	6630336	11	6609105	2917251	3074493		NC_000011.10:6609104:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.580A>G (p.Asn194Asp)	ILK|TAF10	N194D, N60D	Primary familial hypertrophic cardiomyopathy|not specified	VCV000532032	11	6630349	11	6609118	532032	526945	rs761882549	NC_000011.10:6609117:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.581A>C (p.Asn194Thr)	ILK|TAF10	N60T, N194T	Primary familial hypertrophic cardiomyopathy	VCV002133983	11	6630350	11	6609119	2133983	2188529		NC_000011.10:6609118:A:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	May 5, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.586C>G (p.Leu196Val)	TAF10|ILK	L196V, L62V	Primary familial hypertrophic cardiomyopathy	VCV001023101	11	6630355	11	6609124	1023101	1009847	rs1855236652	NC_000011.10:6609123:C:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Mar 3, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.588G>A (p.Leu196=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001631832	11	6630357	11	6609126	1631832	1597634	rs2134561396	NC_000011.10:6609125:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Feb 11, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.590C>T (p.Thr197Met)	ILK|TAF10	T197M, T63M	ILK-related cardiomyopathy|Primary familial hypertrophic cardiomyopathy	VCV001435677	11	6630359	11	6609128	1435677	1500673	rs767383055	NC_000011.10:6609127:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.591G>A (p.Thr197=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001750498	11	6630360	11	6609129	1750498	1803648		NC_000011.10:6609128:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 19, 2023	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.595C>T (p.Leu199Phe)	ILK|TAF10	L65F, L199F	not specified	VCV003528911	11	6630364	11	6609133	3528911	3686646		NC_000011.10:6609132:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.597C>A (p.Leu199=)	ILK|TAF10		not specified	VCV001750812	11	6630366	11	6609135	1750812	1803962		NC_000011.10:6609134:C:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Aug 24, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.600C>T (p.Asn200=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000390027	11	6630369	11	6609138	390027	374186	rs760482273	NC_000011.10:6609137:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Mar 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.601G>A (p.Glu201Lys)	ILK|TAF10	E201K, E67K	not specified|Primary familial hypertrophic cardiomyopathy	VCV000373741	11	6630370	11	6609139	373741	359902	rs1057518584	NC_000011.10:6609138:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.610T>G (p.Ser204Ala)	ILK|TAF10	S204A, S70A	Primary familial hypertrophic cardiomyopathy|not specified	VCV002566095	11	6630379	11	6609148	2566095	2728880		NC_000011.10:6609147:T:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.613G>A (p.Gly205Arg)	ILK|TAF10	G205R, G71R	not specified|Primary familial hypertrophic cardiomyopathy	VCV001429019	11	6630382	11	6609151	1429019	1457983	rs757473698	NC_000011.10:6609150:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.614G>A (p.Gly205Glu)	ILK|TAF10	G71E, G205E	not specified|Primary familial hypertrophic cardiomyopathy	VCV000864128	11	6630383	11	6609152	864128	838782	rs548542841	NC_000011.10:6609151:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.618+5C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002167376	11	6630392	11	6609161	2167376	1906496		NC_000011.10:6609160:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Jan 15, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.618+10G>A	TAF10|ILK		not specified	VCV000227444	11	6630397	11	6609166	227444	230224	rs876657478	NC_000011.10:6609165:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	May 26, 2015	criteria provided, single submitter							
NM_004517.4(ILK):c.618+16_618+18del	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002055943	11	6630400 - 6630402	11	6609169 - 6609171	2055943	2116393		NC_000011.10:6609168:CTTCTT:CTT	Microsatellite	3 prime UTR variant|intron variant	Likely benign	Nov 17, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.618+19del	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002728122	11	6630406	11	6609175	2728122	2889460		NC_000011.10:6609174:G:	Deletion	3 prime UTR variant|intron variant	Likely benign	Jan 26, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.618+23T>C	ILK|TAF10		not provided	VCV000671242	11	6630410	11	6609179	671242	665958	rs11826498	NC_000011.10:6609178:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.619-18C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001530019	11	6630512	11	6609281	1530019	1665375	rs377752465	NC_000011.10:6609280:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Mar 27, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.619-13A>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002805084	11	6630517	11	6609286	2805084	2967468		NC_000011.10:6609285:A:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jan 13, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.619-12C>A	ILK|TAF10		not provided|Primary familial hypertrophic cardiomyopathy	VCV000681504	11	6630518	11	6609287	681504	666117	rs1300032922	NC_000011.10:6609286:C:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.619-11C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001570757	11	6630519	11	6609288	1570757	1645985	rs573765878	NC_000011.10:6609287:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jan 22, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.619-9G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001634954	11	6630521	11	6609290	1634954	1610680	rs1235027162	NC_000011.10:6609289:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.619-6C>T	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy|not provided	VCV000239949	11	6630524	11	6609293	239949	241205	rs149710421	NC_000011.10:6609292:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.619C>G (p.Leu207Val)	ILK|TAF10	L146V, L207V, L73V	Primary familial hypertrophic cardiomyopathy	VCV002108691	11	6630530	11	6609299	2108691	2170449		NC_000011.10:6609298:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.625_636del (p.Lys209_Trp212del)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV003608238	11	6630533 - 6630544	11	6609302 - 6609313	3608238	3740516		NC_000011.10:6609301:TGGAAGGGCCGCTGG:TGG	Deletion	inframe_deletion|3 prime UTR variant	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.628G>A (p.Gly210Ser)	ILK|TAF10	G149S, G210S, G76S	Primary familial hypertrophic cardiomyopathy	VCV003620079	11	6630539	11	6609308	3620079	3753919		NC_000011.10:6609307:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.631C>T (p.Arg211Cys)	ILK|TAF10	R211C, R77C, R150C	not specified|Primary familial hypertrophic cardiomyopathy	VCV000155799	11	6630542	11	6609311	155799	165551	rs140322345	NC_000011.10:6609310:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 22, 2024	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.632G>A (p.Arg211His)	ILK|TAF10	R211H, R150H, R77H	not specified|Primary familial hypertrophic cardiomyopathy	VCV000517629	11	6630543	11	6609312	517629	497395	rs200288502	NC_000011.10:6609311:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.636G>T (p.Trp212Cys)	ILK|TAF10	W78C, W151C, W212C	not specified|Primary familial hypertrophic cardiomyopathy	VCV001036458	11	6630547	11	6609316	1036458	1030406	rs758462999	NC_000011.10:6609315:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.639G>A (p.Gln213=)	ILK|TAF10		not specified	VCV001753277	11	6630550	11	6609319	1753277	1811601		NC_000011.10:6609318:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 26, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.641G>A (p.Gly214Asp)	ILK|TAF10	G153D, G80D, G214D	Primary familial hypertrophic cardiomyopathy	VCV002056752	11	6630552	11	6609321	2056752	2109455		NC_000011.10:6609320:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.644A>G (p.Asn215Ser)	ILK|TAF10	N215S, N154S, N81S	not specified	VCV002447021	11	6630555	11	6609324	2447021	2422145		NC_000011.10:6609323:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 27, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.647A>G (p.Asp216Gly)	ILK|TAF10	D155G, D216G, D82G	Primary familial hypertrophic cardiomyopathy	VCV001299856	11	6630558	11	6609327	1299856	1289908	rs576804127	NC_000011.10:6609326:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 17, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.648C>T (p.Asp216=)	ILK|TAF10		ILK-related disorder	VCV003058794	11	6630559	11	6609328	3058794	3200410		NC_000011.10:6609327:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 14, 2019	no assertion criteria provided							
NM_004517.4(ILK):c.649A>T (p.Ile217Phe)	ILK|TAF10	I156F, I217F, I83F	Primary familial hypertrophic cardiomyopathy	VCV002162940	11	6630560	11	6609329	2162940	1891357		NC_000011.10:6609328:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 4, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.650T>C (p.Ile217Thr)	ILK|TAF10	I217T, I83T, I156T	not specified	VCV003109499	11	6630561	11	6609330	3109499	3271305		NC_000011.10:6609329:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.654C>T (p.Val218=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001092657	11	6630565	11	6609334	1092657	1078509	rs770261491	NC_000011.10:6609333:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.655G>A (p.Val219Met)	ILK|TAF10	V158M, V85M, V219M	Primary familial hypertrophic cardiomyopathy|not specified	VCV001754192	11	6630566	11	6609335	1754192	1804747		NC_000011.10:6609334:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.656T>A (p.Val219Glu)	ILK|TAF10	V158E, V219E, V85E	Primary familial hypertrophic cardiomyopathy	VCV001375344	11	6630567	11	6609336	1375344	1392117	rs2134563739	NC_000011.10:6609335:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 16, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.669G>T (p.Lys223Asn)	ILK|TAF10	K223N, K162N, K89N	Primary familial hypertrophic cardiomyopathy|not provided	VCV000201791	11	6630580	11	6609349	201791	198368	rs147368550	NC_000011.10:6609348:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.673C>T (p.Arg225Ter)	ILK|TAF10	R164*, R225*, R91*	Primary familial hypertrophic cardiomyopathy	VCV001021993	11	6630584	11	6609353	1021993	1009848	rs1179732298	NC_000011.10:6609352:C:T	single nucleotide variant	nonsense|3 prime UTR variant	Uncertain significance	Jan 8, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.674G>A (p.Arg225Gln)	ILK|TAF10	R164Q, R225Q, R91Q	Primary familial hypertrophic cardiomyopathy	VCV001057874	11	6630585	11	6609354	1057874	1047391	rs1315052873	NC_000011.10:6609353:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.679T>A (p.Trp227Arg)	ILK|TAF10	W227R, W166R, W93R	Primary familial hypertrophic cardiomyopathy|not specified	VCV001755497	11	6630590	11	6609359	1755497	1818787		NC_000011.10:6609358:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.686C>T (p.Thr229Ile)	ILK|TAF10	T168I, T229I, T95I	not specified	VCV002624752	11	6630597	11	6609366	2624752	2790247		NC_000011.10:6609365:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.690G>A (p.Arg230=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002882039	11	6630601	11	6609370	2882039	3034228		NC_000011.10:6609369:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 2, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.695G>A (p.Ser232Asn)	ILK|TAF10	S98N, S171N, S232N	Primary familial hypertrophic cardiomyopathy	VCV001360119	11	6630606	11	6609375	1360119	1473992	rs2134564162	NC_000011.10:6609374:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 13, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.700G>A (p.Asp234Asn)	ILK|TAF10	D100N, D173N, D234N	Primary familial hypertrophic cardiomyopathy	VCV002124502	11	6630611	11	6609380	2124502	2184963		NC_000011.10:6609379:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 11, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.707A>T (p.Asn236Ile)	ILK|TAF10	N236I, N102I, N175I	Primary familial hypertrophic cardiomyopathy	VCV001954158	11	6630618	11	6609387	1954158	2008275		NC_000011.10:6609386:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.707A>G (p.Asn236Ser)	ILK|TAF10	N236S, N175S, N102S	Primary familial hypertrophic cardiomyopathy|not provided	VCV000449745	11	6630618	11	6609387	449745	444862	rs145571020	NC_000011.10:6609386:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications							
NM_004517.4(ILK):c.708T>C (p.Asn236=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000762017	11	6630619	11	6609388	762017	768615	rs766701483	NC_000011.10:6609387:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 6, 2019	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.713A>T (p.Glu238Val)	ILK|TAF10	E104V, E177V, E238V	not specified	VCV002451635	11	6630624	11	6609393	2451635	2429939		NC_000011.10:6609392:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 19, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.714G>A (p.Glu238=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV000756875	11	6630625	11	6609394	756875	768616	rs1346943702	NC_000011.10:6609393:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	May 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.721C>T (p.Arg241Trp)	ILK|TAF10	R107W, R180W, R241W	Primary familial hypertrophic cardiomyopathy	VCV001175020	11	6630632	11	6609401	1175020	1164401	rs765298592	NC_000011.10:6609400:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.723G>A (p.Arg241=)	TAF10|ILK		Primary familial hypertrophic cardiomyopathy	VCV003625418	11	6630634	11	6609403	3625418	3751905		NC_000011.10:6609402:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.728+13G>A	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000509891	11	6630652	11	6609421	509891	503350	rs368709206	NC_000011.10:6609420:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.728+17C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV003629187	11	6630656	11	6609425	3629187	3753061		NC_000011.10:6609424:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Dec 2, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.729-20C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002178650	11	6630723	11	6609492	2178650	1912526		NC_000011.10:6609491:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.729-15C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002203567	11	6630728	11	6609497	2203567	1934857		NC_000011.10:6609496:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 17, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.729-14C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002849397	11	6630729	11	6609498	2849397	3009186		NC_000011.10:6609497:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jan 7, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.729-7C>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided	VCV000385176	11	6630736	11	6609505	385176	374191	rs375371977	NC_000011.10:6609504:C:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Dec 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.729-3T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002719448	11	6630740	11	6609509	2719448	2870084		NC_000011.10:6609508:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.734T>A (p.Phe245Tyr)	ILK|TAF10	F245Y, F111Y, F184Y	Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy	VCV000222653	11	6630748	11	6609517	222653	224435	rs869025438	NC_000011.10:6609516:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.738G>A (p.Ser246=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002915866	11	6630752	11	6609521	2915866	3074416		NC_000011.10:6609520:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.738G>T (p.Ser246=)	ILK|TAF10		not specified	VCV001758656	11	6630752	11	6609521	1758656	1819367		NC_000011.10:6609520:G:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 2, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.738G>C (p.Ser246=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001089383	11	6630752	11	6609521	1089383	1078510	rs369519432	NC_000011.10:6609520:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 19, 2020	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.757G>C (p.Val253Leu)	ILK|TAF10	V253L, V119L, V192L	Primary familial hypertrophic cardiomyopathy	VCV000954856	11	6630771	11	6609540	954856	947585	rs1855289433	NC_000011.10:6609539:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 2, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.758T>C (p.Val253Ala)	ILK|TAF10	V192A, V253A, V119A	Primary familial hypertrophic cardiomyopathy|not specified	VCV002451636	11	6630772	11	6609541	2451636	2429940		NC_000011.10:6609540:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.764G>T (p.Gly255Val)	ILK|TAF10	G121V, G194V, G255V	not provided	VCV001677354	11	6630778	11	6609547	1677354	1669044	rs1385486344	NC_000011.10:6609546:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.766G>A (p.Ala256Thr)	ILK|TAF10	A195T, A122T, A256T	Primary familial hypertrophic cardiomyopathy	VCV001034581	11	6630780	11	6609549	1034581	1030407	rs779240233	NC_000011.10:6609548:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 23, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.771C>T (p.Cys257=)	ILK|TAF10		not specified	VCV003224309	11	6630785	11	6609554	3224309	3390114		NC_000011.10:6609553:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.777T>C (p.Ser259=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002023390	11	6630791	11	6609560	2023390	2083871		NC_000011.10:6609559:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 10, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.778C>T (p.Pro260Ser)	ILK|TAF10	P260S, P126S, P199S	Primary familial hypertrophic cardiomyopathy|not specified	VCV000228750	11	6630792	11	6609561	228750	230225	rs750354350	NC_000011.10:6609560:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.781C>T (p.Pro261Ser)	ILK|TAF10	P261S, P200S, P127S	not specified	VCV003528900	11	6630795	11	6609564	3528900	3686635		NC_000011.10:6609563:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 24, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.785C>T (p.Ala262Val)	ILK|TAF10	A262V, A128V, A201V	Variant of unknown significance	VCV000050371	11	6630799	11	6609568	50371	59494	rs387907366	NC_000011.10:6609567:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 31, 2007	no assertion criteria provided							
NM_004517.4(ILK):c.786T>A (p.Ala262=)	ILK|TAF10		not specified	VCV003528914	11	6630800	11	6609569	3528914	3686649		NC_000011.10:6609568:T:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 10, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.790C>T (p.His264Tyr)	ILK|TAF10	H203Y, H264Y, H130Y	not specified|Primary familial hypertrophic cardiomyopathy	VCV001761171	11	6630804	11	6609573	1761171	1816786		NC_000011.10:6609572:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.792T>A (p.His264Gln)	ILK|TAF10	H264Q, H203Q, H130Q	not specified	VCV002334859	11	6630806	11	6609575	2334859	2325040		NC_000011.10:6609574:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.794C>T (p.Pro265Leu)	ILK|TAF10	P265L, P131L, P204L	Primary familial hypertrophic cardiomyopathy	VCV002150521	11	6630808	11	6609577	2150521	1891899		NC_000011.10:6609576:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.799C>G (p.Leu267Val)	ILK|TAF10	L133V, L267V, L206V	Primary familial hypertrophic cardiomyopathy	VCV000938001	11	6630813	11	6609582	938001	935694	rs1236862935	NC_000011.10:6609581:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 8, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.801C>T (p.Leu267=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001148290	11	6630815	11	6609584	1148290	1142579	rs769777649	NC_000011.10:6609583:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	May 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.815T>G (p.Met272Arg)	ILK|TAF10	M138R, M272R, M211R	not specified|Primary familial hypertrophic cardiomyopathy	VCV001762225	11	6630829	11	6609598	1762225	1820361		NC_000011.10:6609597:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.816G>A (p.Met272Ile)	ILK|TAF10	M138I, M272I, M211I	not specified	VCV001762272	11	6630830	11	6609599	1762272	1820408		NC_000011.10:6609598:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.818C>T (p.Pro273Leu)	ILK|TAF10	P139L, P212L, P273L	not specified	VCV003224310	11	6630832	11	6609601	3224310	3390115		NC_000011.10:6609600:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.818C>A (p.Pro273Gln)	ILK|TAF10	P212Q, P273Q, P139Q	not specified	VCV001762342	11	6630832	11	6609601	1762342	1820477		NC_000011.10:6609600:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 12, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.818C>G (p.Pro273Arg)	ILK|TAF10	P139R, P212R, P273R	Primary familial hypertrophic cardiomyopathy	VCV001093663	11	6630832	11	6609601	1093663	1078511	rs774113906	NC_000011.10:6609600:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.819G>C (p.Pro273=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002910649	11	6630833	11	6609602	2910649	3073117		NC_000011.10:6609601:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 4, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.819G>A (p.Pro273=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided|not specified	VCV000137590	11	6630833	11	6609602	137590	141293	rs1043390	NC_000011.10:6609601:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.828C>T (p.Ser276=)	ILK|TAF10		not specified	VCV003224311	11	6630842	11	6609611	3224311	3390116		NC_000011.10:6609610:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 16, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.836A>G (p.Asn279Ser)	ILK|TAF10	N279S, N145S, N218S	Primary familial hypertrophic cardiomyopathy	VCV001360505	11	6630850	11	6609619	1360505	1363947	rs1855298413	NC_000011.10:6609618:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.837T>C (p.Asn279=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001601841	11	6630851	11	6609620	1601841	1523784	rs1441279272	NC_000011.10:6609619:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.838G>A (p.Val280Ile)	ILK|TAF10	V219I, V280I, V146I	Primary familial hypertrophic cardiomyopathy	VCV003021508	11	6630852	11	6609621	3021508	3172713		NC_000011.10:6609620:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 20, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.846T>C (p.His282=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001763505	11	6630860	11	6609629	1763505	1824229		NC_000011.10:6609628:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.852C>G (p.Gly284=)	ILK|TAF10		not specified	VCV003528899	11	6630866	11	6609635	3528899	3686634		NC_000011.10:6609634:C:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 20, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.856+1G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001514564	11	6630871	11	6609640	1514564	1485607	rs1589940179	NC_000011.10:6609639:G:A	single nucleotide variant	3 prime UTR variant|splice donor variant	Uncertain significance	Jan 3, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.856+3G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001392527	11	6630873	11	6609642	1392527	1502430	rs750836317	NC_000011.10:6609641:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Mar 14, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.856+14T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001582599	11	6630884	11	6609653	1582599	1566869	rs1855301341	NC_000011.10:6609652:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Sep 25, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.856+16G>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001987293	11	6630886	11	6609655	1987293	2043835		NC_000011.10:6609654:G:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jul 17, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.857-19_857-17del	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002914213	11	6630936 - 6630938	11	6609705 - 6609707	2914213	3071025		NC_000011.10:6609704:GAC:	Deletion	3 prime UTR variant|intron variant	Likely benign	Nov 19, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.857-12G>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002750792	11	6630943	11	6609712	2750792	2915855		NC_000011.10:6609711:G:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.857-12G>A	ILK|TAF10		not provided|not specified|Primary familial hypertrophic cardiomyopathy	VCV000227445	11	6630943	11	6609712	227445	230226	rs145172848	NC_000011.10:6609711:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign/Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.857-10C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001461227	11	6630945	11	6609714	1461227	1498058	rs1589940447	NC_000011.10:6609713:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.857-10C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000754976	11	6630945	11	6609714	754976	775935	rs1589940447	NC_000011.10:6609713:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Sep 29, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.861C>T (p.Phe287=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001099321	11	6630959	11	6609728	1099321	1100249	rs779980137	NC_000011.10:6609727:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Apr 12, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.862G>A (p.Val288Ile)	ILK|TAF10	V154I, V288I, V227I	Primary familial hypertrophic cardiomyopathy|not specified	VCV001418246	11	6630960	11	6609729	1418246	1397300	rs377702962	NC_000011.10:6609728:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.864C>G (p.Val288=)	ILK|TAF10		not specified	VCV002566096	11	6630962	11	6609731	2566096	2728881		NC_000011.10:6609730:C:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 31, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.864C>T (p.Val288=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000516117	11	6630962	11	6609731	516117	503360	rs147558204	NC_000011.10:6609730:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.865G>A (p.Val289Met)	ILK|TAF10	V289M, V155M, V228M	Primary familial hypertrophic cardiomyopathy	VCV002152913	11	6630963	11	6609732	2152913	1885174		NC_000011.10:6609731:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.869A>C (p.Asp290Ala)	ILK|TAF10	D229A, D290A, D156A	not specified	VCV003285934	11	6630967	11	6609736	3285934	3444674		NC_000011.10:6609735:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.876C>T (p.Ser292=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001764594	11	6630974	11	6609743	1764594	1814415		NC_000011.10:6609742:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	May 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.879G>A (p.Gln293=)	ILK|TAF10		not specified	VCV003528897	11	6630977	11	6609746	3528897	3686632		NC_000011.10:6609745:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.879G>C (p.Gln293His)	TAF10|ILK	Q159H, Q293H, Q232H	See cases	VCV000931821	11	6630977	11	6609746	931821	919383	rs751035884	NC_000011.10:6609745:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 25, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.885G>C (p.Val295=)	ILK|TAF10		not specified	VCV001764920	11	6630983	11	6609752	1764920	1824414		NC_000011.10:6609751:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 24, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.885G>A (p.Val295=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001137672	11	6630983	11	6609752	1137672	1121732	rs767184450	NC_000011.10:6609751:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 12, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.887A>C (p.Lys296Thr)	TAF10|ILK	K162T, K235T, K296T	not provided	VCV001711315	11	6630985	11	6609754	1711315	1709731		NC_000011.10:6609753:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 1, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.895T>C (p.Leu299=)	ILK|TAF10		not specified	VCV001765260	11	6630993	11	6609762	1765260	1824754		NC_000011.10:6609761:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 13, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.901A>T (p.Met301Leu)	ILK|TAF10	M167L, M240L, M301L	not specified	VCV001765491	11	6630999	11	6609768	1765491	1821132		NC_000011.10:6609767:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.906A>G (p.Ala302=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy|not provided	VCV001292639	11	6631004	11	6609773	1292639	1282445	rs757145727	NC_000011.10:6609772:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.909G>A (p.Arg303=)	TAF10|ILK		not specified|Primary familial hypertrophic cardiomyopathy	VCV001098990	11	6631007	11	6609776	1098990	1100250	rs372479913	NC_000011.10:6609775:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 11, 2020	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.918C>T (p.Ala306=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified|not provided	VCV000137591	11	6631016	11	6609785	137591	141294	rs2292195	NC_000011.10:6609784:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.924A>G (p.Leu308=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001582144	11	6631022	11	6609791	1582144	1654105	rs758354683	NC_000011.10:6609790:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 1, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.930A>T (p.Thr310=)	TAF10|ILK		Primary familial hypertrophic cardiomyopathy	VCV001141381	11	6631028	11	6609797	1141381	1142580	rs1855316786	NC_000011.10:6609796:A:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 17, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.931C>T (p.Leu311=)	ILK|TAF10		not specified	VCV003528915	11	6631029	11	6609798	3528915	3686650		NC_000011.10:6609797:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 10, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.943A>G (p.Ile315Val)	ILK|TAF10	I315V, I254V, I181V	not specified	VCV003285932	11	6631041	11	6609810	3285932	3444672		NC_000011.10:6609809:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 2, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.944T>C (p.Ile315Thr)	ILK|TAF10	I181T, I315T, I254T	Primary familial hypertrophic cardiomyopathy	VCV002834217	11	6631042	11	6609811	2834217	2995326		NC_000011.10:6609810:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 3, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.945C>T (p.Ile315=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002038355	11	6631043	11	6609812	2038355	2101424		NC_000011.10:6609811:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.953A>T (p.His318Leu)	ILK|TAF10	H184L, H257L, H318L	not specified	VCV003224312	11	6631051	11	6609820	3224312	3390117		NC_000011.10:6609819:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.958C>T (p.Leu320Phe)	ILK|TAF10	L259F, L186F, L320F	Primary familial hypertrophic cardiomyopathy	VCV002807874	11	6631056	11	6609825	2807874	2971515		NC_000011.10:6609824:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	May 9, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.958C>A (p.Leu320Ile)	ILK|TAF10	L186I, L259I, L320I	not specified|Primary familial hypertrophic cardiomyopathy	VCV001056292	11	6631056	11	6609825	1056292	1047392	rs912510389	NC_000011.10:6609824:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.958C>G (p.Leu320Val)	ILK|TAF10	L186V, L259V, L320V	ILK-related disorder|Primary familial hypertrophic cardiomyopathy	VCV001015536	11	6631056	11	6609825	1015536	1009849	rs912510389	NC_000011.10:6609824:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.961A>G (p.Asn321Asp)	ILK|TAF10	N260D, N187D, N321D	Primary familial hypertrophic cardiomyopathy	VCV002189218	11	6631059	11	6609828	2189218	1911561		NC_000011.10:6609827:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.962A>G (p.Asn321Ser)	TAF10|ILK	N321S, N187S, N260S	Primary familial hypertrophic cardiomyopathy|not specified	VCV000180372	11	6631060	11	6609829	180372	178648	rs570806647	NC_000011.10:6609828:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.968G>A (p.Arg323His)	ILK|TAF10	R323H, R189H, R262H	Primary familial hypertrophic cardiomyopathy|not specified	VCV001041952	11	6631066	11	6609835	1041952	1030408	rs199652324	NC_000011.10:6609834:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.969T>C (p.Arg323=)	ILK|TAF10		not provided	VCV000746514	11	6631067	11	6609836	746514	752828	rs1383782529	NC_000011.10:6609835:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	May 18, 2018	criteria provided, single submitter							
NM_004517.4(ILK):c.972T>C (p.Ser324=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002180487	11	6631070	11	6609839	2180487	1909303		NC_000011.10:6609838:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 25, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.978+3G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV003006070	11	6631079	11	6609848	3006070	3168942		NC_000011.10:6609847:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.978+5_979-38dup	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001002892	11	6631080 - 6631081	11	6609849 - 6609850	1002892	994662	rs1392922443	NC_000011.10:6609849:GGCCACAAGCTCACTCCTGGCCCAGGCCCCAAAAGCCCTTTGCCTATCT:GGCCACAAGCTCACTCCTGGCCCAGGCCCCAAAAGCCCTTTGCCTATCTGGCCACAAGCTCACTCCTGGCCCAGGCCCCAAAAGCCCTTTGCCTATCT	Duplication	3 prime UTR variant|intron variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.978+10C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001634810	11	6631086	11	6609855	1634810	1546762	rs1440762009	NC_000011.10:6609854:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.978+13G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002791864	11	6631089	11	6609858	2791864	2950407		NC_000011.10:6609857:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Sep 19, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.979-20A>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001537572	11	6631147	11	6609916	1537572	1649851	rs2134569653	NC_000011.10:6609915:A:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jun 29, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.979-17dup	TAF10|ILK		not specified|Primary familial hypertrophic cardiomyopathy	VCV000512718	11	6631149 - 6631150	11	6609918 - 6609919	512718	503361	rs1554899641	NC_000011.10:6609918:T:TT	Duplication	3 prime UTR variant|intron variant	Likely benign	Apr 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.979-14T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002749127	11	6631153	11	6609922	2749127	2912468		NC_000011.10:6609921:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Aug 8, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.995C>T (p.Thr332Ile)	ILK|TAF10	T198I, T271I, T332I	Primary familial hypertrophic cardiomyopathy|not specified	VCV002877417	11	6631183	11	6609952	2877417	3041626		NC_000011.10:6609951:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1001G>A (p.Arg334Gln)	ILK|TAF10	R334Q, R200Q, R273Q	Primary familial hypertrophic cardiomyopathy|not specified	VCV001769485	11	6631189	11	6609958	1769485	1835920		NC_000011.10:6609957:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1003A>G (p.Ile335Val)	ILK|TAF10	I201V, I274V, I335V	not specified	VCV003528913	11	6631191	11	6609960	3528913	3686648		NC_000011.10:6609959:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1014T>C (p.Ala338=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001603025	11	6631202	11	6609971	1603025	1611364	rs1336585654	NC_000011.10:6609970:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Sep 1, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1015G>T (p.Asp339Tyr)	ILK|TAF10	D205Y, D339Y, D278Y	not specified	VCV003528912	11	6631203	11	6609972	3528912	3686647		NC_000011.10:6609971:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 1, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1018G>A (p.Val340Ile)	TAF10|ILK	V340I, V206I, V279I	Primary familial hypertrophic cardiomyopathy	VCV001519859	11	6631206	11	6609975	1519859	1517148	rs2134570003	NC_000011.10:6609974:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 11, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1020C>T (p.Val340=)	ILK|TAF10		not provided	VCV000091924	11	6631208	11	6609977	91924	97402	rs386352317	NC_000011.10:6609976:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Uncertain significance		no assertion criteria provided							
NM_004517.4(ILK):c.1022A>G (p.Lys341Arg)	ILK|TAF10	K207R, K280R, K341R	Primary familial hypertrophic cardiomyopathy	VCV001351868	11	6631210	11	6609979	1351868	1486256	rs781099551	NC_000011.10:6609978:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 17, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1031T>A (p.Phe344Tyr)	ILK|TAF10	F283Y, F344Y, F210Y	Primary familial hypertrophic cardiomyopathy	VCV002833823	11	6631219	11	6609988	2833823	2998763		NC_000011.10:6609987:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1032C>T (p.Phe344=)	ILK|TAF10		not specified	VCV001771553	11	6631220	11	6609989	1771553	1832749		NC_000011.10:6609988:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Apr 22, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1035A>G (p.Gln345=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV003627387	11	6631223	11	6609992	3627387	3752567		NC_000011.10:6609991:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 19, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1037G>A (p.Cys346Tyr)	ILK|TAF10	C212Y, C285Y, C346Y	not specified	VCV003224300	11	6631225	11	6609994	3224300	3390105		NC_000011.10:6609993:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1038T>A (p.Cys346Ter)	ILK|TAF10	C212*, C285*, C346*	Primary familial hypertrophic cardiomyopathy	VCV003620540	11	6631226	11	6609995	3620540	3750924		NC_000011.10:6609994:T:A	single nucleotide variant	nonsense|3 prime UTR variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1041T>C (p.Pro347=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001553194	11	6631229	11	6609998	1553194	1552978	rs748450237	NC_000011.10:6609997:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1045C>T (p.Arg349Cys)	ILK|TAF10	R215C, R288C, R349C	Primary familial hypertrophic cardiomyopathy	VCV000941413	11	6631233	11	6610002	941413	935695	rs1257537906	NC_000011.10:6610001:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 9, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.1046G>T (p.Arg349Leu)	TAF10|ILK	R215L, R288L, R349L	Primary familial hypertrophic cardiomyopathy	VCV001401842	11	6631234	11	6610003	1401842	1457501	rs377094824	NC_000011.10:6610002:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1046G>A (p.Arg349His)	ILK|TAF10	R288H, R349H, R215H	Primary familial hypertrophic cardiomyopathy	VCV000864632	11	6631234	11	6610003	864632	838783	rs377094824	NC_000011.10:6610002:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1048A>C (p.Met350Leu)	TAF10|ILK	M216L, M289L, M350L	Primary familial hypertrophic cardiomyopathy	VCV003615317	11	6631236	11	6610005	3615317	3739385		NC_000011.10:6610004:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1052A>G (p.Tyr351Cys)	ILK|TAF10	Y217C, Y290C, Y351C	Primary familial hypertrophic cardiomyopathy	VCV001515351	11	6631240	11	6610009	1515351	1505216	rs989434950	NC_000011.10:6610008:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 16, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1066G>A (p.Val356Ile)	ILK|TAF10	V222I, V295I, V356I	not specified|Primary familial hypertrophic cardiomyopathy|not provided	VCV001317930	11	6631254	11	6610023	1317930	1309024	rs199558648	NC_000011.10:6610022:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Apr 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1068A>T (p.Val356=)	ILK|TAF10		not specified	VCV003224301	11	6631256	11	6610025	3224301	3390106		NC_000011.10:6610024:A:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 7, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1074C>T (p.Pro358=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001944833	11	6631262	11	6610031	1944833	1998532		NC_000011.10:6610030:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 11, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1075G>A (p.Glu359Lys)	ILK|TAF10	E359K, E225K, E298K	Primary familial hypertrophic cardiomyopathy	VCV001940519	11	6631263	11	6610032	1940519	2004553		NC_000011.10:6610031:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1077A>C (p.Glu359Asp)	ILK|TAF10	E225D, E298D, E359D	not specified	VCV003528896	11	6631265	11	6610034	3528896	3686631		NC_000011.10:6610033:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1078+5G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001348494	11	6631271	11	6610040	1348494	1455882	rs1855340750	NC_000011.10:6610039:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	May 30, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1079-18C>T	ILK|TAF10		not provided|not specified|Primary familial hypertrophic cardiomyopathy	VCV000137592	11	6631361	11	6610130	137592	141295	rs111833028	NC_000011.10:6610129:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1079-15G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001552523	11	6631364	11	6610133	1552523	1586602	rs553103939	NC_000011.10:6610132:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jul 7, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1079-14C>A	ILK|TAF10		not specified	VCV000390942	11	6631365	11	6610134	390942	372295	rs776003441	NC_000011.10:6610133:C:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Nov 18, 2016	criteria provided, single submitter							
NM_004517.4(ILK):c.1079-10A>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided	VCV000681788	11	6631369	11	6610138	681788	665115	rs769283883	NC_000011.10:6610137:A:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1079-8C>T	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV000506519	11	6631371	11	6610140	506519	503366	rs972559469	NC_000011.10:6610139:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Aug 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1086G>C (p.Gln362His)	ILK|TAF10	Q301H, Q362H, Q228H	not provided|Primary familial hypertrophic cardiomyopathy	VCV001401293	11	6631386	11	6610155	1401293	1379280	rs142990615	NC_000011.10:6610154:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1089G>T (p.Lys363Asn)	ILK|TAF10	K363N, K302N, K229N	not specified	VCV001788593	11	6631389	11	6610158	1788593	1844653		NC_000011.10:6610157:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 11, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1089G>A (p.Lys363=)	ILK|TAF10		not specified	VCV001788571	11	6631389	11	6610158	1788571	1844631		NC_000011.10:6610157:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 30, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.1090A>C (p.Lys364Gln)	ILK|TAF10	K230Q, K303Q, K364Q	not specified	VCV002566094	11	6631390	11	6610159	2566094	2728879		NC_000011.10:6610158:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1093C>G (p.Pro365Ala)	ILK|TAF10	P365A, P304A, P231A	not specified	VCV002451634	11	6631393	11	6610162	2451634	2429938		NC_000011.10:6610161:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 14, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1105_1108del (p.Asn369fs)	ILK|TAF10	N235fs, N308fs, N369fs	Primary familial hypertrophic cardiomyopathy|ILK-related disorder	VCV002078334	11	6631402 - 6631405	11	6610171 - 6610174	2078334	2138849		NC_000011.10:6610170:ACAAACA:ACA	Deletion	frameshift variant|3 prime UTR variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1104A>C (p.Thr368=)	ILK|TAF10		not specified	VCV001793154	11	6631404	11	6610173	1793154	1848667		NC_000011.10:6610172:A:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 5, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.1111C>T (p.Arg371Cys)	TAF10|ILK	R237C, R371C, R310C	not specified|Primary familial hypertrophic cardiomyopathy	VCV001421965	11	6631411	11	6610180	1421965	1337579	rs759330457	NC_000011.10:6610179:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1112G>A (p.Arg371His)	ILK|TAF10	R371H, R237H, R310H	not provided|Primary familial hypertrophic cardiomyopathy	VCV000429387	11	6631412	11	6610181	429387	421873	rs370480843	NC_000011.10:6610180:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Mar 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1122C>T (p.Asp374=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001093070	11	6631422	11	6610191	1093070	1078512	rs1237951284	NC_000011.10:6610190:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1123A>C (p.Met375Leu)	ILK|TAF10	M314L, M241L, M375L	Primary familial hypertrophic cardiomyopathy	VCV002958250	11	6631423	11	6610192	2958250	3116008		NC_000011.10:6610191:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1136C>T (p.Ala379Val)	ILK|TAF10	A245V, A318V, A379V	Primary familial hypertrophic cardiomyopathy	VCV002919202	11	6631436	11	6610205	2919202	3075126		NC_000011.10:6610204:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1137A>T (p.Ala379=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002745554	11	6631437	11	6610206	2745554	2907612		NC_000011.10:6610205:A:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Aug 11, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1140G>C (p.Val380=)	ILK|TAF10		not provided|not specified	VCV001233743	11	6631440	11	6610209	1233743	1225410	rs757576502	NC_000011.10:6610208:G:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	May 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1149G>A (p.Trp383Ter)	ILK|TAF10	W249*, W322*, W383*	Primary familial hypertrophic cardiomyopathy	VCV000839951	11	6631449	11	6610218	839951	838784	rs1855363075	NC_000011.10:6610217:G:A	single nucleotide variant	nonsense|3 prime UTR variant	Uncertain significance	Nov 22, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.1153C>A (p.Leu385Met)	ILK|TAF10	L251M, L324M, L385M	not specified	VCV003224302	11	6631453	11	6610222	3224302	3390107		NC_000011.10:6610221:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1159A>G (p.Thr387Ala)	ILK|TAF10	T387A, T253A, T326A	not specified	VCV003528901	11	6631459	11	6610228	3528901	3686636		NC_000011.10:6610227:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1162C>T (p.Arg388Trp)	TAF10|ILK	R327W, R254W, R388W	not specified|Primary familial hypertrophic cardiomyopathy	VCV000952349	11	6631462	11	6610231	952349	926346	rs776996356	NC_000011.10:6610230:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1163G>A (p.Arg388Gln)	ILK|TAF10	R327Q, R388Q, R254Q	not specified	VCV001737561	11	6631463	11	6610232	1737561	1787425		NC_000011.10:6610231:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 6, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1168G>A (p.Val390Ile)	ILK|TAF10	V256I, V329I, V390I	not specified	VCV003528898	11	6631468	11	6610237	3528898	3686633		NC_000011.10:6610236:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1169T>C (p.Val390Ala)	ILK|TAF10	V256A, V390A, V329A	Primary familial hypertrophic cardiomyopathy	VCV002970852	11	6631469	11	6610238	2970852	3135928		NC_000011.10:6610237:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1180G>A (p.Asp394Asn)	ILK|TAF10	D394N, D333N, D260N	Primary familial hypertrophic cardiomyopathy	VCV000180373	11	6631480	11	6610249	180373	178649	rs730880112	NC_000011.10:6610248:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 25, 2014	no assertion criteria provided							
NM_004517.4(ILK):c.1182C>T (p.Asp394=)	ILK|TAF10		not specified	VCV003285933	11	6631482	11	6610251	3285933	3444673		NC_000011.10:6610250:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1188C>A (p.Ser396=)	ILK|TAF10		not specified|Primary familial hypertrophic cardiomyopathy	VCV001122732	11	6631488	11	6610257	1122732	1121733	rs769331209	NC_000011.10:6610256:C:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1197G>A (p.Glu399=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV000385387	11	6631497	11	6610266	385387	372521	rs1057522211	NC_000011.10:6610265:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1204A>G (p.Met402Val)	ILK|TAF10	M268V, M341V, M402V	not specified	VCV003224303	11	6631504	11	6610273	3224303	3390108		NC_000011.10:6610272:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1209+13C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001577439	11	6631522	11	6610291	1577439	1553475	rs1159966605	NC_000011.10:6610290:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jan 19, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1209+15G>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002836082	11	6631524	11	6610293	2836082	2992069		NC_000011.10:6610292:G:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1209+18T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002917456	11	6631527	11	6610296	2917456	3074698		NC_000011.10:6610295:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Feb 24, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1209+52A>C	ILK|TAF10		not provided	VCV001317680	11	6631561	11	6610330	1317680	1306623	rs145787931	NC_000011.10:6610329:A:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Nov 20, 2019	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1210-20T>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001540274	11	6631673	11	6610442	1540274	1544891	rs2134575363	NC_000011.10:6610441:T:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-18T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002123788	11	6631675	11	6610444	2123788	2173916		NC_000011.10:6610443:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Apr 9, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-17T>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002063674	11	6631676	11	6610445	2063674	2121530		NC_000011.10:6610444:T:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-13C>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001568880	11	6631680	11	6610449	1568880	1634481	rs2134575533	NC_000011.10:6610448:C:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jun 27, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-11T>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001968018	11	6631682	11	6610451	1968018	2031893		NC_000011.10:6610450:T:G	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Apr 19, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-11T>C	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001904347	11	6631682	11	6610451	1904347	1964579		NC_000011.10:6610450:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 16, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-5C>T	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001078897	11	6631688	11	6610457	1078897	1078513	rs755264665	NC_000011.10:6610456:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Oct 7, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1210-4G>A	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not provided	VCV001284194	11	6631689	11	6610458	1284194	1274050	rs181426034	NC_000011.10:6610457:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Benign/Likely benign	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1210-2A>G	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001419062	11	6631691	11	6610460	1419062	1390622	rs748640419	NC_000011.10:6610459:A:G	single nucleotide variant	3 prime UTR variant|splice acceptor variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1214C>T (p.Ala405Val)	ILK|TAF10	A271V, A344V, A405V	Primary familial hypertrophic cardiomyopathy	VCV001503272	11	6631697	11	6610466	1503272	1400990	rs2134575735	NC_000011.10:6610465:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 25, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1216T>C (p.Leu406=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV002566098	11	6631699	11	6610468	2566098	2728883		NC_000011.10:6610467:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1227T>C (p.Leu409=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001155356	11	6631710	11	6610479	1155356	1142581	rs1855398103	NC_000011.10:6610478:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Feb 26, 2019	criteria provided, single submitter							
NM_004517.4(ILK):c.1228C>T (p.Arg410Trp)	ILK|TAF10	R276W, R349W, R410W	Primary familial hypertrophic cardiomyopathy	VCV002917244	11	6631711	11	6610480	2917244	3074486		NC_000011.10:6610479:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1229G>A (p.Arg410Gln)	ILK|TAF10	R276Q, R349Q, R410Q	Primary familial hypertrophic cardiomyopathy	VCV002190128	11	6631712	11	6610481	2190128	1918877		NC_000011.10:6610480:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1238T>A (p.Ile413Asn)	ILK|TAF10	I279N, I413N, I352N	Primary familial hypertrophic cardiomyopathy	VCV000834388	11	6631721	11	6610490	834388	838785	rs1855399834	NC_000011.10:6610489:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1245A>G (p.Pro415=)	ILK|TAF10		not specified	VCV003224304	11	6631728	11	6610497	3224304	3390109		NC_000011.10:6610496:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Mar 10, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1252T>C (p.Ser418Pro)	ILK|TAF10	S418P, S357P, S284P	Primary familial hypertrophic cardiomyopathy	VCV000463180	11	6631735	11	6610504	463180	461894	rs1554900104	NC_000011.10:6610503:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1256C>T (p.Pro419Leu)	ILK|TAF10	P285L, P358L, P419L	not provided|Primary familial hypertrophic cardiomyopathy	VCV000939806	11	6631739	11	6610508	939806	935696	rs1855401354	NC_000011.10:6610507:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1258C>T (p.His420Tyr)	ILK|TAF10	H420Y, H286Y, H359Y	Primary familial hypertrophic cardiomyopathy	VCV000532033	11	6631741	11	6610510	532033	526701	rs1554900107	NC_000011.10:6610509:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Dec 22, 2017	criteria provided, single submitter							
NM_004517.4(ILK):c.1259_1260del (p.His420fs)	ILK|TAF10	H286fs, H359fs, H420fs	Primary familial hypertrophic cardiomyopathy	VCV003607283	11	6631742 - 6631743	11	6610511 - 6610512	3607283	3747166		NC_000011.10:6610510:AT:	Deletion	frameshift variant|3 prime UTR variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1263G>A (p.Val421=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV001981324	11	6631746	11	6610515	1981324	2035392		NC_000011.10:6610514:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 17, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1263G>T (p.Val421=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV000701421	11	6631746	11	6610515	701421	687813	rs146642176	NC_000011.10:6610514:G:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Dec 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1266T>C (p.Cys422=)	TAF10|ILK		not specified|Primary familial hypertrophic cardiomyopathy	VCV001104592	11	6631749	11	6610518	1104592	1100251	rs952639348	NC_000011.10:6610517:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1270C>G (p.Leu424Val)	ILK|TAF10	L290V, L363V, L424V	Primary familial hypertrophic cardiomyopathy	VCV001391455	11	6631753	11	6610522	1391455	1390135	rs2134576590	NC_000011.10:6610521:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1275G>A (p.Met425Ile)	ILK|TAF10	M291I, M364I, M425I	Primary familial hypertrophic cardiomyopathy	VCV002042515	11	6631758	11	6610527	2042515	2099107		NC_000011.10:6610526:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1285A>G (p.Met429Val)	ILK|TAF10	M429V, M368V, M295V	not specified	VCV000504981	11	6631768	11	6610537	504981	497206	rs1554900131	NC_000011.10:6610536:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Apr 26, 2016	criteria provided, single submitter							
NM_004517.4(ILK):c.1294G>A (p.Asp432Asn)	ILK|TAF10	D298N, D371N, D432N	not specified	VCV003528917	11	6631777	11	6610546	3528917	3686652		NC_000011.10:6610545:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jul 27, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1296C>T (p.Asp432=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV000387389	11	6631779	11	6610548	387389	371602	rs765285266	NC_000011.10:6610547:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1301C>A (p.Ala434Glu)	ILK|TAF10	A300E, A373E, A434E	Primary familial hypertrophic cardiomyopathy	VCV001063121	11	6631784	11	6610553	1063121	1047393	rs2134576889	NC_000011.10:6610552:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 1, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.1305G>A (p.Lys435=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002854319	11	6631788	11	6610557	2854319	3010685		NC_000011.10:6610556:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 24, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1306C>T (p.Arg436Ter)	ILK|TAF10	R302*, R375*, R436*	Primary familial hypertrophic cardiomyopathy	VCV000654152	11	6631789	11	6610558	654152	640339	rs1477497923	NC_000011.10:6610557:C:T	single nucleotide variant	nonsense|3 prime UTR variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1307G>A (p.Arg436Gln)	ILK|TAF10	R302Q, R375Q, R436Q	Primary familial hypertrophic cardiomyopathy	VCV001022333	11	6631790	11	6610559	1022333	1009850	rs773362090	NC_000011.10:6610558:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Feb 12, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.1313A>C (p.Lys438Thr)	ILK|TAF10	K304T, K438T, K377T	not specified	VCV001769715	11	6631796	11	6610565	1769715	1832201		NC_000011.10:6610564:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Sep 2, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.1321_1322del (p.Met441fs)	ILK|TAF10	M307fs, M380fs, M441fs	Primary familial hypertrophic cardiomyopathy	VCV001027026	11	6631804 - 6631805	11	6610573 - 6610574	1027026	1009851	rs1855405973	NC_000011.10:6610572:AT:	Deletion	frameshift variant|3 prime UTR variant	Uncertain significance	Oct 7, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.1322T>G (p.Met441Arg)	TAF10|ILK	M307R, M380R, M441R	Primary familial hypertrophic cardiomyopathy	VCV001057190	11	6631805	11	6610574	1057190	1047394	rs1452306438	NC_000011.10:6610573:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.1331C>A (p.Pro444His)	ILK|TAF10	P310H, P444H, P383H	Primary familial hypertrophic cardiomyopathy	VCV001041773	11	6631814	11	6610583	1041773	1030409	rs959927407	NC_000011.10:6610582:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Jan 31, 2020	criteria provided, single submitter							
NM_004517.4(ILK):c.1338T>C (p.Leu446=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy|not specified	VCV001538766	11	6631821	11	6610590	1538766	1544251	rs144996026	NC_000011.10:6610589:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jul 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_004517.4(ILK):c.1344G>A (p.Lys448=)	ILK|TAF10		not specified	VCV003528895	11	6631827	11	6610596	3528895	3686630		NC_000011.10:6610595:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_004517.4(ILK):c.1347G>A (p.Met449Ile)	ILK|TAF10	M315I, M449I, M388I	Primary familial hypertrophic cardiomyopathy	VCV001466199	11	6631830	11	6610599	1466199	1449024	rs1323106962	NC_000011.10:6610598:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1353C>G (p.Asp451Glu)	ILK|TAF10	D451E, D317E, D390E	Primary familial hypertrophic cardiomyopathy	VCV000578151	11	6631836	11	6610605	578151	566070	rs1234007742	NC_000011.10:6610604:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Aug 30, 2021	criteria provided, single submitter							
NM_004517.4(ILK):c.1355A>C (p.Lys452Thr)	ILK|TAF10	K318T, K391T, K452T	Primary familial hypertrophic cardiomyopathy	VCV002037064	11	6631838	11	6610607	2037064	2097557		NC_000011.10:6610606:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1356G>A (p.Lys452=)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV002740773	11	6631839	11	6610608	2740773	2902840		NC_000011.10:6610607:G:A	single nucleotide variant	synonymous variant|3 prime UTR variant	Likely benign	Jun 17, 2023	criteria provided, single submitter							
NM_004517.4(ILK):c.1357T>C (p.Ter453Gln)	ILK|TAF10		Primary familial hypertrophic cardiomyopathy	VCV000967682	11	6631840	11	6610609	967682	956590	rs756620800	NC_000011.10:6610608:T:C	single nucleotide variant	stop lost|3 prime UTR variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_004517.4(ILK):c.*2A>G	ILK|TAF10		not specified	VCV000390863	11	6631844	11	6610613	390863	374197	rs778105132	NC_000011.10:6610612:A:G	single nucleotide variant	3 prime UTR variant	Likely benign	Nov 15, 2016	criteria provided, single submitter							
NM_004517.4(ILK):c.*61C>T	ILK|TAF10		not provided	VCV001318108	11	6631903	11	6610672	1318108	1309202	rs151106636	NC_000011.10:6610671:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Jul 26, 2018	criteria provided, multiple submitters, no conflicts							
NC_000011.9:g.(?_6625502)_(6631842_?)dup	ILK		Primary familial hypertrophic cardiomyopathy	VCV003244598	11	6625502 - 6631842			3244598	3403520			Duplication		Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
GRCh37/hg19 11p15.5-15.4(chr11:230615-8821443)x3	ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|C11orf42|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FHIP1B|GATD1|HPX|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RNH1|RPL27A|RPLP2|RRM1|RRP8|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|STIM1|STK33|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM80|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|ZNF195|ZNF214|ZNF215		Russell-Silver syndrome	VCV002503522	11	230615 - 8821443			2503522	2668708			copy number gain		Pathogenic	May 25, 2023	criteria provided, single submitter							
NC_000011.9:g.(?_6625502)_(6662844_?)dup	DCHS1|ILK|TAF10|TPP1		not provided	VCV002424751	11	6625502 - 6662844			2424751	1949828			Duplication		Uncertain significance	Jun 29, 2022	criteria provided, single submitter							
NC_000011.9:g.(?_6411829)_(6662844_?)dup	APBB1|ARFIP2|DCHS1|DNHD1|HPX|ILK|RRP8|SMPD1|TAF10|TIMM10B|TPP1|TRIM3		not provided	VCV002423019	11	6411829 - 6662844			2423019	1949245			Duplication		Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
GRCh37/hg19 11p15.5-15.4(chr11:230616-8250724)x3	CAVIN3|CCKBR|CD151|CD81|CDHR5|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|C11orf42|CARS1|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FHIP1B|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RNH1|RPLP2|RRM1|RRP8|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|STIM1|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM80|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|ZNF195|ZNF214|ZNF215		not provided	VCV001807629	11	230616 - 8250724			1807629	1864633			copy number gain		Pathogenic	Dec 23, 2021	criteria provided, single submitter							
GRCh37/hg19 11p15.5-14.2(chr11:230615-26881146)x3	CYP2R1|DBX1|DRD4|AMPD3|ANO3|ANO5|ANO9|AP2A2|ABCC8|ADM|AKIP1|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CARS1|CAVIN3|CCDC179|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CSRP3|CTR9|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DENND5A|DKK3|DNHD1|DUSP8|E2F8|EIF3F|EIF4G2|EPS8L2|FANCF|FAR1|FHIP1B|GALNT18|GAS2|GATD1|GTF2H1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPS5|HPX|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|IGSF22|ILK|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNC1|KCNJ11|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LDHAL6A|LDHC|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MYOD1|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PARVA|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PRMT3|PSMA1|PSMD13|PTDSS2|PTH|PTPN5|RASSF10|RASSF7|RBMXL2|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SERGEF|SIGIRR|SIRT3|SLC17A6|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SYT8|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A|TMEM9B|TNNI2|TNNT3|TOLLIP|TPH1|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|UEVLD|USH1C|USP47|WEE1|ZBED5|ZDHHC13|ZNF143|ZNF195|ZNF214|ZNF215		See cases	VCV001707435	11	230615 - 26881146			1707435	1705743			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 11p15.4(chr11:6502523-7248333)x3	ARFIP2|DCHS1|DNHD1|ILK|MRPL17|NLRP14|OR10A2|OR10A4|OR10A5|OR2AG1|OR2AG2|OR2D2|OR2D3|OR6A2|RBMXL2|RRP8|TAF10|TIMM10B|TPP1|ZNF214|ZNF215		not provided	VCV001340891	11	6502523 - 7248333			1340891	1332099			copy number gain		Uncertain significance	Jul 9, 2020	no assertion criteria provided							
NC_000011.9:g.(?_6559613)_(6640631_?)del	DNHD1|ILK|RRP8|TAF10|TPP1		not provided	VCV001073290	11	6559613 - 6640631			1073290	1057562			Deletion		Pathogenic	Apr 9, 2020	criteria provided, single submitter							
NC_000011.9:g.(?_5709028)_(6640651_?)dup	APBB1|ARFIP2|C11orf42|CAVIN3|CCKBR|CNGA4|DNHD1|FHIP1B|HPX|ILK|OR52B2|OR52E4|OR52E6|OR52E8|OR52L1|OR52N1|OR52N2|OR52N4|OR52N5|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|RRP8|SMPD1|TAF10|TIMM10B|TPP1|TRIM22|TRIM3		not provided	VCV001027249	11	5709028 - 6640651			1027249	1001676			Duplication		Uncertain significance	Sep 16, 2020	criteria provided, single submitter							
GRCh37/hg19 11p15.5-15.4(chr11:210300-8664358)x3	CHRNA10|CNGA4|CRACR2B|OR52B2|OR52B4|OR52B6|TPP1|OR52D1|OR52E2|CTSD|CYB5R2|TRIM21|TRIM22|EIF3F|OR52E4|OR52E6|TRIM3|TRIM34|ZNF195|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|OR52E8|OR52H1|OR52M1|OR52I1|OR52I2|OR52K1|OR52N1|OR52N2|OR52N4|LMNTD2|LMNTD2-AS1|FHIP1B|GATD1|LMO1|LRRC56|LSP1|OR52J3|OR52K2|OR52L1|MIR210|MIR210HG|MMP26|MOB2|HPX|IRF7|EPS8L2|TRIM5|TRIM6|TRIM66|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|B4GALNT4|BRSK2|C11orf21|C11orf40|C11orf42|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|DCHS1|DEAF1|DNHD1|DRD4|DUSP8|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PPFIBP2|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RIC8A|RNH1|RPLP2|RRM1|RRP8|SCT|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|STIM1|STK33|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM80|TNNI2|TNNT3|TOLLIP|ZNF214|ZNF215		Silver-Russell syndrome 1	VCV000981209	11	210300 - 8664358			981209	969295			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 11p15.5-13(chr11:235934-33826995)x3	CALCB|CARS1|FSHB|GALNT18|GAS2|MRGPRG|MRGPRX1|OR2D2|OR2D3|OR51A2|OR51A4|OR52E6|PIK3C2A|PKP3|SAA2|SAA2-SAA4|TMEM86A|TMEM9B|ZNF143|ZNF195|ZNF214|ZNF215|TRIM34|TRIM5|TRIM6|TNNT3|TOLLIP|TPH1|SAA4|SCT|SCUBE2|SERGEF|SIGIRR|SIRT3|SLC17A6|SAAL1|SBF2|TNNI2|TPP1|TRIM21|TRIM22|TRIM3|PLEKHA7|PNPLA2|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|PPFIBP2|OR52H1|PRMT3|PRRG4|PSMD13|PTDSS2|POLR2L|PSMA1|OR52E8|OR52I1|OR52I2|OR52J3|OR51E2|OR51F1|OR51A7|OR51B4|MRPL17|MYOD1|MRPL23|MTRNR2L8|MUC15|MUC2|OR51B6|OR51D1|OR51E1|OR51F2|OR51B2|GATD1|GTF2H1|IFITM5|KCNC1|HPS5|KCNJ11|LGR4|LIN7C|HIPK3|HPX|OR51B5|MRGPRX2|MUC5AC|MUC5B|MUC6|CAVIN3|CCDC73|CCKBR|CD151|CD59|CD81|CDHR5|ADM|AKIP1|AMPD3|ANO3|CSTF3|CTR9|CTSD|CYB5R2|CRACR2B|CSNK2A3|CSRP3|CCDC179|CCDC34|MRGPRX3|MRGPRX4|ABCC8|ANO5|ANO9|AP2A2|APBB1|ARFIP2|ARL14EP|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BBOX1|BDNF|BDNF-AS|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|C11orf91|CALCA|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CYP2R1|DBX1|DCDC1|DCHS1|DEAF1|DENND2B|DENND5A|DEPDC7|DKK3|DNAJC24|DNHD1|DRD4|DUSP8|E2F8|EIF3F|EIF3M|EIF4G2|ELP4|EPS8L2|FANCF|FAR1|FBXO3|FHIP1B|FIBIN|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|IGSF22|ILK|IMMP1L|KCNA4|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KIAA1549L|KIF18A|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LDHAL6A|LDHC|LINC00294|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|METTL15|MICAL2|MICALCL|MIR210|MIR210HG|MIR610|MMP26|MOB2|MPPED2|MRGPRE|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PARVA|PAX6|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PTH|PTPN5|QSER1|RASSF10|RASSF7|RBMXL2|RCN1|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SYT8|SYT9|TAF10|TALDO1|TCP11L1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|UEVLD|USH1C|USP47|WEE1|WT1|WT1-AS|ZBED5|ZDHHC13		not provided	VCV000815395	11	235934 - 33826995			815395	803604			copy number gain		Pathogenic	Oct 24, 2018	no assertion criteria provided							
GRCh37/hg19 11p15.4(chr11:5896551-6719852)x3	APBB1|ARFIP2|C11orf42|CAVIN3|CCKBR|CNGA4|DCHS1|DNHD1|FHIP1B|HPX|ILK|MRPL17|OR52B2|OR52E4|OR52L1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B4|RRP8|SMPD1|TAF10|TIMM10B|TPP1|TRIM3		not provided	VCV000689280	11	5896551 - 6719852			689280	676872			copy number gain		Uncertain significance	Apr 5, 2018	no assertion criteria provided							
GRCh37/hg19 11p15.4(chr11:6607967-6796286)x3	DCHS1|ILK|MRPL17|OR2AG2|RRP8|TAF10|TPP1		not provided	VCV000685541	11	6607967 - 6796286			685541	673133			copy number gain		Uncertain significance	Jun 9, 2017	no assertion criteria provided							
GRCh37/hg19 11p15.5-15.3(chr11:193146-12643136)	C11orf40|C11orf42|MRPL17|MRPL23|OR10A3|OR10A4|MUC5AC|MUC5B|NRIP3|NUP98|MUC2|OLFML1|OR10A2|OR52E6|DRD4|DUSP8|CTR9|CTSD|CAVIN3|CCKBR|CD151|CRACR2B|CD81|CDHR5|CARS1|ADM|AKIP1|AMPD3|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BET1L|BRSK2|C11orf16|C11orf21|CDKN1C|CEND1|CHID1|CHRNA10|CIMAP1A|CNGA4|CSNK2A3|MTRNR2L8|CYB5R2|DCHS1|DEAF1|DENND2B|DENND5A|DKK3|DNHD1|EIF3F|EIF4G2|EPS8L2|FHIP1B|GALNT18|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IPO7|IRAG1|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PARVA|PGAP2|PGGHG|PPFIBP2|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RIC8A|RNF141|RNH1|RPL27A|RPLP2|RRM1|RRP8|SBF2|SCGB1C1|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|STIM1|STK33|SWAP70|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|USP47|WEE1|ZBED5|ZNF143|ZNF195|ZNF214|ZNF215		Silver-Russell syndrome 1	VCV000625559	11	193146 - 12643136			625559	613863			copy number gain		Pathogenic	Nov 1, 2018	criteria provided, single submitter							
GRCh37/hg19 11p15.5-15.1(chr11:230615-17099213)x3	ADM|AKIP1|AMPD3|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CTR9|CTSD|CYB5R2|CYP2R1|DCHS1|DEAF1|DENND2B|DENND5A|DKK3|DNHD1|DRD4|DUSP8|EIF3F|EIF4G2|EPS8L2|FAR1|FHIP1B|GALNT18|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|LMNTD2|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2-AS1|LMO1|LRRC56|LSP1|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MTRNR2L8|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NRIP3|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PARVA|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PKP3|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PSMA1|PSMD13|PTDSS2|PTH|RASSF10|RASSF7|RBMXL2|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SBF2|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|SOX6|SPON1|STIM1|STK33|SWAP70|SYT8|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|USP47|WEE1|ZBED5|ZNF143|ZNF195|ZNF214|ZNF215		not provided	VCV000563883	11	230615 - 17099213			563883	555067			copy number gain		Pathogenic	Nov 13, 2017	no assertion criteria provided							
GRCh37/hg19 11p15.5-15.4(chr11:230615-9704511)x3	AKIP1|ANO9|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BRSK2|C11orf16|C11orf21|C11orf40|C11orf42|CARS1|CAVIN3|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|CRACR2B|CTSD|CYB5R2|DCHS1|DEAF1|DENND2B|DENND5A|DNHD1|DRD4|DUSP8|EIF3F|EPS8L2|FHIP1B|GATD1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPX|HRAS|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|ILK|INS|INS-IGF2|IPO7|IRF7|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|MIR210|MIR210HG|MMP26|MOB2|MRGPRE|MRGPRG|MRPL17|MRPL23|MUC2|MUC5AC|MUC5B|MUC6|NAP1L4|NLRP10|NLRP14|NLRP6|NRIP3|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PGAP2|PGGHG|PPFIBP2|PHLDA2|PHRF1|PIDD1|PKP3|PNPLA2|POLR2L|PSMD13|PTDSS2|RASSF7|RBMXL2|RHOG|RIC3|RNH1|RPL27A|RPLP2|RRM1|RRP8|SCT|SCUBE2|SIGIRR|SIRT3|SLC22A18|SLC22A18AS|SLC25A22|SMPD1|SNORA3B|STIM1|STK33|SWAP70|SYT8|SYT9|TAF10|TALDO1|TH|TIMM10B|TMEM41B|TMEM80|TMEM9B|TNNI2|TNNT3|TOLLIP|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|WEE1|ZNF143|ZNF195|ZNF214|ZNF215		not provided	VCV000563880	11	230615 - 9704511			563880	555064			copy number gain		Pathogenic	Mar 30, 2018	no assertion criteria provided							
GRCh37/hg19 11p15.5-13(chr11:230615-31995219)x3	DEAF1|DENND2B|DENND5A|DKK3|DNAJC24|DNHD1|DRD4|DUSP8|E2F8|EIF3F|EIF4G2|ELP4|EPS8L2|FANCF|FAR1|FHIP1B|FIBIN|FSHB|GALNT18|GAS2|GATD1|GTF2H1|H19|HBB|HBD|HBE1|HBG1|HBG2|HPS5|HPX|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IGF2|IGF2-AS|IGSF22|ILK|IMMP1L|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNA4|KCNC1|KCNJ11|KCNQ1|KCNQ1DN|KCNQ1OT1|KIF18A|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LDHAL6A|LDHC|LGR4|LIN7C|LMNTD2|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|METTL15|MICAL2|MICALCL|MIR210|MIR210HG|MIR610|MMP26|MOB2|MPPED2|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MYOD1|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OTOG|OVCH2|PARVA|PAX6|PDE3B|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PNPLA2|POLR2L|PPFIBP2|PRMT3|PSMA1|PSMD13|PTDSS2|PTH|PTPN5|RASSF10|RASSF7|RBMXL2|RHOG|RIC3|RNF141|RNH1|RPL27A|RPLP2|RPS13|RRAS2|RRM1|RRP8|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SERGEF|SIGIRR|SIRT3|SLC17A6|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SYT8|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A|TMEM9B|TNNI2|TNNT3|TOLLIP|TPH1|TPP1|TRIM21|TRIM22|TRIM3|TRIM34|TRIM5|TRIM6|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|UEVLD|USH1C|USP47|WEE1|ZBED5|ZDHHC13|ZNF143|ZNF195|ZNF214|ZNF215|ABCC8|ADM|AKIP1|AMPD3|ANO3|ANO5|ANO9|AP2A2|APBB1|ARFIP2|ARL14EP|ART1|ART5|ASCL2|ASCL3|B4GALNT4|BBOX1|BDNF|BDNF-AS|BMAL1|BRSK2|BTBD10|C11orf16|C11orf21|C11orf40|C11orf42|C11orf58|CALCA|CALCB|CARS1|CAVIN3|CCDC179|CCDC34|CCKBR|CD151|CD81|CDHR5|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COPB1|CRACR2B|CSNK2A3|CSRP3|CTR9|CTSD|CYB5R2|CYP2R1|DBX1|DCDC1|DCHS1		See cases	VCV000441985	11	230615 - 31995219			441985	435647			copy number gain		Pathogenic	May 16, 2014	no assertion criteria provided							
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)	AAMDC|AASDHPPT|ABCC8|ABCG4|ABTB2|ACAD8|ACAT1|ACCS|ACCSL|ACER3|ACP2|ACRV1|ACTN3|ACY3|ADAMTS15|ADAMTS8|ADM|AGBL2|AHNAK|AIP|AKIP1|ALDH3B1|ALDH3B2|ALG8|ALG9|ALKBH3|ALKBH8|ALX4|AMBRA1|AMOTL1|AMPD3|ANAPC15|ANGPTL5|ANKK1|ANKRD13D|ANKRD42|ANKRD49|ANO1|ANO3|ANO5|ANO9|AP2A2|AP5B1|APBB1|API5|APIP|APLNR|APLP2|APOA1|APOA4|APOA5|APOC3|AQP11|ARAP1|ARAP1-AS2|ARCN1|ARFGAP2|ARFIP2|ARHGAP1|ARHGAP20|ARHGAP32|ARHGAP42|ARHGEF12|ARHGEF17|ARHGEF17-AS1|ARL14EP|ARL2|ARRB1|ART1|ART5|ASCL2|ASCL3|ASRGL1|ATG13|ATG16L2|ATG2A|ATL3|ATM|ATP5MG|B3GAT1|B3GAT3|B3GNT6|B4GALNT4|B4GAT1|BACE1|BACE1-AS|BAD|BANF1|BARX2|BATF2|BBOX1|BBS1|BCL9L|BCO2|BDNF|BDNF-AS|BEST1|BIRC2|BIRC3|BLID|BMAL1|BRMS1|BRSK2|BSCL2|BSX|BTBD10|BTBD18|BTG4|BUD13|C11orf16|C11orf21|C11orf24|C11orf40|C11orf42|C11orf52|C11orf54|C11orf58|C11orf65|C11orf68|C11orf71|C11orf86|C11orf87|C11orf91|C11orf96|C1QTNF4|C1QTNF5|C2CD2L|C2CD3|CABP2|CABP4|CADM1|CALCA|CALCB|CAPN1|CAPN5|CAPRIN1|CARD16|CARD17|CARD18|CARNS1|CARS1|CASP1|CASP12|CASP4|CASP5|CAT|CATSPER1|CATSPERZ|CAVIN3|CBL|CBLIF|CCDC15|CCDC179|CCDC34|CCDC73|CCDC81|CCDC82|CCDC83|CCDC85B|CCDC86|CCDC87|CCDC88B|CCDC89|CCDC90B|CCKBR|CCND1|CCS|CD151|CD248|CD3D|CD3E|CD3G|CD44|CD5|CD59|CD6|CD81|CD82|CDC42BPG|CDC42EP2|CDCA5|CDHR5|CDK2AP2|CDKN1C|CDON|CELF1|CENATAC|CEND1|CEP126|CEP164|CEP295|CEP57|CFAP300|CFAP68|CFL1|CHEK1|CHID1|CHKA|CHORDC1|CHRDL2|CHRM1|CHRM4|CHRNA10|CHST1|CKAP5|CLCF1|CLDN25|CLMP|CLNS1A|CLP1|CLPB|CNGA4|CNIH2|CNTF|CNTN5|COA4|COMMD9|COPB1|CORO1B|COX8A|CPSF7|CPT1A|CRACR2B|CREB3L1|CREBZF|CRTAM|CRY2|CRYAB|CSKMT|CSNK2A3|CSRP3|CST6|CSTF3|CSTPP1|CTNND1|CTR9|CTSC|CTSD|CTSF|CTSW|CTTN|CUL5|CWC15|CWF19L2|CXCR5|CYB561A3|CYB5R2|CYP2R1|DAGLA|DBX1|DCDC1|DCHS1|DCPS|DCUN1D5|DDB1|DDB2|DDI1|DDIAS|DDX10|DDX25|DDX6|DEAF1|DEFB108B|DENND2B|DENND5A|DEPDC7|DEUP1|DGAT2|DGKZ|DHCR7|DIXDC1|DKK3|DLAT|DLG2|DNAJB13|DNAJC24|DNAJC4|DNHD1|DPAGT1|DPF2|DPP3|DRAP1|DRC12|DRD2|DRD4|DSCAML1|DTX4|DUSP8|DYNC2H1|E2F8|EED|EEF1G|EFEMP2|EHBP1L1|EHD1|EHF|EI24|EIF1AD|EIF3F|EIF3M|EIF4G2|ELF5|ELMOD1|ELP4|EML3|EMSY|ENDOD1|EPS8L2|ESAM|ESRRA|ETS1|EXPH5|EXT2|F2|FADD|FADS1|FADS2|FADS3|FAM111A|FAM111B|FAM118B|FAM168A|FAM180B|FAM181B|FAM76B|FAM86C1P|FAM89B|FANCF|FAR1|FAT3|FAU|FBXO3|FCHSD2|FDX1|FDXACB1|FEN1|FERMT3|FEZ1|FGF19|FGF3|FGF4|FHIP1B|FIBIN|FIBP|FJX1|FKBP2|FLI1|FLRT1|FNBP4|FOLH1|FOLH1B|FOLR1|FOLR2|FOLR3|FOSL1|FOXR1|FOXRED1|FREY1|FRMD8|FSHB|FTH1|FUT4|FXYD2|FXYD6|FXYD6-FXYD2|FZD4|GAB2|GAL|GAL3ST3|GALNT18|GANAB|GAS2|GATD1|GDPD4|GDPD5|GLB1L2|GLB1L3|GLYAT|GLYATL1|GLYATL2|GNG3|GPHA2|GPR137|GPR152|GPR83|GRAMD1B|GRIA4|GRIK4|GRK2|GRM5|GSTP1|GTF2H1|GUCY1A2|H19|H2AX|HARBI1|HBB|HBD|HBE1|HBG1|HBG2|HEPACAM|HEPHL1|HEPN1|HIKESHI|HINFP|HIPK3|HMBS|HNRNPUL2|HOATZ|HPS5|HPX|HRAS|HSD17B12|HSPA8|HSPB2|HTATIP2|HTR3A|HTR3B|HYLS1|HYOU1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IFT46|IFTAP|IGF2|IGF2-AS|IGHMBP2|IGSF22|IGSF9B|IL10RA|IL18|IL18BP|ILK|IMMP1L|INCENP|INPPL1|INS|INS-IGF2|INSC|INTS4|INTS5|IPO7|IRAG1|IRF7|IZUMO1R|JAM3|JAML|JHY|JRKL|KAT5|KBTBD3|KBTBD4|KCNA4|KCNC1|KCNE3|KCNJ1|KCNJ11|KCNJ5|KCNJ5-AS1|KCNK4|KCNK7|KCNQ1|KCNQ1DN|KCNQ1OT1|KCTD14|KCTD21|KDM2A|KDM4D|KDM4E|KIAA1549L|KIF18A|KIRREL3|KLC2|KLHL35|KMT2A|KMT5B|KRTAP5-1|KRTAP5-10|KRTAP5-11|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-7|KRTAP5-8|KRTAP5-9|LAMTOR1|LARGE2|LAYN|LBHD1|LDHA|LDHAL6A|LDHC|LDLRAD3|LGALS12|LGR4|LIN7C|LINC00294|LINC02714|LINC02743|LINC02873|LIPT2|LMNTD2|LMNTD2-AS1|LMO1|LMO2|LOC100132686|LOC101929473|LPXN|LRFN4|LRP4|LRP5|LRRC10B|LRRC32|LRRC4C|LRRC55|LRRC56|LRRN4CL|LRTOMT|LSP1|LTBP3|LTO1|LUZP2|LYVE1|MACROD1|MADD|MADD-AS1|MAJIN|MALAT1|MAML2|MAP3K11|MAP4K2|MAP6|MAPK8IP1|MARK2|MCAM|MDK|ME3|MED17|MED19|MEN1|METTL15|MFRP|MICAL2|MICALCL|MIR100|MIR125B1|MIR130A|MIR139|MIR192|MIR194-2|MIR210|MIR210HG|MIR326|MIR34B|MIR34BHG|MIR34C|MIR610|MIRLET7A2|MMP1|MMP10|MMP12|MMP13|MMP20|MMP26|MMP27|MMP3|MMP7|MMP8|MOB2|MOGAT2|MPEG1|MPPED2|MPZL2|MPZL3|MRE11|MRGPRD|MRGPRE|MRGPRF|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL11|MRPL16|MRPL17|MRPL21|MRPL23|MRPL48|MRPL49|MS4A1|MS4A10|MS4A12|MS4A13|MS4A14|MS4A15|MS4A18|MS4A2|MS4A3|MS4A4A|MS4A4E|MS4A5|MS4A6A|MS4A6E|MS4A7|MS4A8|MSANTD2|MSANTD4|MTA2|MTCH2|MTMR2|MTNR1B|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MUS81|MYBPC3|MYEOV|MYO7A|MYOD1|MYRF|NAA40|NAALAD2|NAALADL1|NADSYN1|NAP1L4|NARS2|NAT10|NAV2|NCAM1|NCAPD3|NCR3LG1|NDUFC2|NDUFC2-KCTD14|NDUFS3|NDUFS8|NDUFV1|NDUFV1-DT|NEAT1|NECTIN1|NELL1|NEU3|NFRKB|NHERF4|NKAPD1|NLRP10|NLRP14|NLRP6|NLRX1|NNMT|NOX4|NPAS4|NPAT|NR1H3|NRGN|NRIP3|NRXN2|NTM|NUCB2|NUDT22|NUDT8|NUMA1|NUP160|NUP98|NXF1|NXPE1|NXPE2|NXPE4|OAF|OLFML1|OMP|OOSP2|OPCML|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR10AG1|OR10G4|OR10G7|OR10G8|OR10G9|OR10Q1|OR10S1|OR10V1|OR10W1|OR1S1|OR1S2|OR2AG1|OR2AG2|OR2AT4|OR2D2|OR2D3|OR4A15|OR4A16|OR4A47|OR4A5|OR4B1|OR4C11|OR4C12|OR4C13|OR4C15|OR4C16|OR4C3|OR4C46|OR4C6|OR4D10|OR4D11|OR4D5|OR4D6|OR4D9|OR4P4|OR4S1|OR4S2|OR4X1|OR4X2|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5A1|OR5A2|OR5AK2|OR5AN1|OR5AP2|OR5AR1|OR5AS1|OR5B12|OR5B17|OR5B2|OR5B21|OR5B3|OR5D13|OR5D14|OR5D16|OR5D18|OR5F1|OR5I1|OR5J2|OR5L1|OR5L2|OR5M1|OR5M10|OR5M11|OR5M3|OR5M8|OR5M9|OR5P2|OR5P3|OR5T1|OR5T2|OR5T3|OR5W2|OR6A2|OR6M1|OR6Q1|OR6T1|OR6X1|OR8A1|OR8B12|OR8B2|OR8B3|OR8B4|OR8B8|OR8D1|OR8D2|OR8D4|OR8G1|OR8G5|OR8H1|OR8H2|OR8H3|OR8I2|OR8J1|OR8J3|OR8K1|OR8K3|OR8K5|OR8U1|OR8U3|OR9G1|OR9G4|OR9I1|OR9Q1|OR9Q2|OSBP|OSBPL5|OTOG|OTUB1|OVCH2|OVOL1|P2RX3|P2RY2|P2RY6|P4HA3|PAAF1|PACS1|PACSIN3|PAFAH1B2|PAK1|PAMR1|PANX1|PANX3|PARVA|PATE1|PATE2|PATE3|PATE4|PATL1|PAX6|PC|PCF11|PCNX3|PCSK7|PDE2A|PDE3B|PDGFD|PDHX|PELI3|PEX16|PGA3|PGA4|PGA5|PGAP2|PGGHG|PGM2L1|PGR|PHF21A|PHLDA2|PHLDB1|PHOX2A|PHRF1|PICALM|PIDD1|PIH1D2|PIK3C2A|PITPNM1|PIWIL4|PKNOX2|PKP3|PLAAT2|PLAAT3|PLAAT4|PLAAT5|PLCB3|PLEKHA7|PLEKHB1|PLET1|PNPLA2|POGLUT3|POLA2|POLD3|POLD4|POLR2G|POLR2L|POU2AF1|POU2AF2|POU2AF3|POU2F3|PPFIA1|PPFIBP2|PPME1|PPP1CA|PPP1R14B|PPP2R1B|PPP2R5B|PPP6R3|PRCP|PRDM10|PRDM11|PRDX5|PRG2|PRG3|PRMT3|PRPF19|PRR5L|PRRG4|PRSS23|PSMA1|PSMC3|PSMD13|PTDSS2|PTGDR2|PTH|PTPMT1|PTPN5|PTPRCAP|PTPRJ|PTS|PUS3|PYGM|QSER1|RAB1B|RAB30|RAB38|RAB39A|RAB3IL1|RAB6A|RAD9A|RAG1|RAG2|RAPSN|RASGRP2|RASSF10|RASSF7|RBM14|RBM14-RBM4|RBM4|RBM4B|RBM7|RBMXL2|RCE1|RCN1|RCOR2|RDX|RELA|RELT|REXO2|RHOD|RHOG|RIC3|RIN1|RNASEH2C|RNF121|RNF141|RNF169|RNF214|RNF26|RNH1|ROBO3|ROBO4|ROM1|RPL27A|RPLP2|RPS13|RPS25|RPS3|RPS6KA4|RPS6KB2|RPUSD4|RRAS2|RRM1|RRP8|RSF1|RTN3|RTN4RL2|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SAC3D1|SART1|SAXO4|SBF2|SC5D|SCGB1A1|SCGB1D1|SCGB1D2|SCGB1D4|SCGB2A1|SCGB2A2|SCN2B|SCN3B|SCN4B|SCT|SCUBE2|SCYL1|SDHAF2|SDHD|SELENOH|SERGEF|SERPING1|SERPINH1|SESN3|SF1|SF3B2|SHANK2|SIAE|SIDT2|SIGIRR|SIK2|SIK3|SIPA1|SIRT3|SLC15A3|SLC17A6|SLC1A2|SLC22A10|SLC22A11|SLC22A12|SLC22A18|SLC22A18AS|SLC22A24|SLC22A25|SLC22A6|SLC22A8|SLC22A9|SLC25A22|SLC25A45|SLC29A2|SLC35C1|SLC35F2|SLC36A4|SLC37A2|SLC37A4|SLC39A13|SLC3A2|SLC43A1|SLC43A3|SLC5A12|SLC6A5|SLCO2B1|SLN|SMCO4|SMPD1|SMTNL1|SNHG1|SNORA3B|SNORD15A|SNORD22|SNORD25|SNORD26|SNORD27|SNORD28|SNORD29|SNORD30|SNORD31|SNX15|SNX19|SNX32|SORL1|SOX6|SPA17|SPATA19|SPCS2|SPDYC|SPI1|SPINDOC|SPON1|SPTBN2|SPTY2D1|SRPRA|SRSF8|SSH3|SSRP1|ST14|ST3GAL4|STARD10|STIM1|STIP1|STK33|STT3A|STX3|STX5|SVIP|SWAP70|SYT12|SYT13|SYT7|SYT8|SYT9|SYTL2|SYVN1|TAF10|TAF1D|TAF6L|TAGLN|TALDO1|TBC1D10C|TBCEL|TBRG1|TBX10|TCIRG1|TCN1|TCP11L1|TEAD1|TECTA|TENM4|TESMIN|TEX12|TH|THAP12|THRSP|THY1|THYN1|TIGD3|TIMM10|TIMM10B|TIMM8B|TIRAP|TKFC|TLCD5|TM7SF2|TMEM109|TMEM123|TMEM126A|TMEM126B|TMEM132A|TMEM133|TMEM134|TMEM135|TMEM138|TMEM151A|TMEM179B|TMEM216|TMEM218|TMEM223|TMEM225|TMEM25|TMEM258|TMEM41B|TMEM45B|TMEM80|TMEM86A|TMEM9B|TMPRSS13|TMPRSS4|TMPRSS5|TMX2|TNKS1BP1|TNNI2|TNNT3|TOLLIP|TOP6BL|TP53AIP1|TP53I11|TPBGL|TPCN2|TPH1|TPP1|TRAF6|TRAPPC4|TREH|TRIM21|TRIM22|TRIM29|TRIM3|TRIM34|TRIM44|TRIM48|TRIM49|TRIM49B|TRIM49C|TRIM49D1|TRIM49D2|TRIM5|TRIM51|TRIM6|TRIM64|TRIM64B|TRIM64C|TRIM66|TRIM68|TRIM77|TRMT112|TRPC6|TRPM5|TRPT1|TSG101|TSGA10IP|TSKU|TSPAN18|TSPAN32|TSPAN4|TSSC4|TTC12|TTC17|TTC36|TTC9C|TUB|TUT1|TYR|UBASH3B|UBE2L6|UBE4A|UBQLN3|UBQLNL|UBTFL1|UBXN1|UCP2|UCP3|UEVLD|UNC93B1|UPK2|UQCC3|USH1C|USP2|USP28|USP35|USP47|UVRAG|VEGFB|VPS11|VPS26B|VPS37C|VPS51|VSIG2|VSTM5|VWA5A|VWCE|WDR74|WEE1|WNT11|WT1|WT1-AS|XRRA1|YAP1|YIF1A|YPEL4|ZBED5|ZBTB16|ZBTB3|ZBTB44|ZC3H12C|ZDHHC13|ZDHHC24|ZDHHC5|ZFP91|ZFPL1|ZFTA|ZNF143|ZNF195|ZNF202|ZNF214|ZNF215|ZNF408|ZNF705E|ZNHIT2|ZNRD2|ZP1|ZPR1|ZW10		See cases	VCV000441904	11	230616 - 134938470			441904	435566			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)x3	SLC37A4|SNORD26|SNORD27|ST3GAL4|TAGLN|TALDO1|TBC1D10C|TBCEL|TBRG1|TBX10|TCIRG1|SYT12|SYT13|SYT7|SYT8|SNORD31|SNX15|SNX19|SNX32|SORL1|SOX6|SPA17|SPATA19|SPI1|SPINDOC|SPON1|SPTBN2|SPCS2|SPDYC|STARD10|STIM1|STT3A|SWAP70|STIP1|STK33|STX3|STX5|SLC39A13|SLC43A3|SLC43A1|SLC5A12|SLC6A5|ACCS|ACCSL|ACER3|ACP2|ACAD8|ACAT1|SLCO2B1|SLN|SMCO4|SMPD1|SLC3A2|SVIP|SNORD28|SNORD29|SNORD30|ACRV1|AAMDC|AASDHPPT|ABCC8|ABCG4|ABTB2|ACTN3|ACY3|ADAMTS15|SLC35F2|SLC36A4|SLC37A2|SMTNL1|SNHG1|SNORA3B|SNORD15A|SNORD22|SNORD25|SPTY2D1|SRPRA|SRSF8|SSH3|SSRP1|ST14|SYT9|SYTL2|SYVN1|TAF10|TAF1D|TAF6L|TCN1|TCP11L1|TEAD1|TECTA|TENM4|TESMIN|TEX12|TH|THAP12|THRSP|THY1|THYN1|TIGD3|TIMM10|TIMM10B|TIMM8B|TIRAP|TKFC|TLCD5|TM7SF2|TMEM109|TMEM123|TMEM126A|TMEM126B|TMEM132A|TMEM133|TMEM134|TMEM135|TMEM138|TMEM151A|TMEM179B|TMEM216|TMEM218|TMEM223|TMEM225|TMEM25|TMEM258|TMEM41B|TMEM45B|TMEM80|TMEM86A|TMEM9B|TMPRSS13|TMPRSS4|TMPRSS5|TMX2|TNKS1BP1|TNNI2|TNNT3|TOLLIP|TOP6BL|TP53AIP1|TP53I11|TPBGL|TPCN2|TPH1|TPP1|TRAF6|TRAPPC4|TREH|TRIM21|TRIM22|TRIM29|TRIM3|TRIM34|TRIM44|TRIM48|TRIM49|TRIM49B|TRIM49C|TRIM49D1|TRIM49D2|TRIM5|TRIM51|TRIM6|TRIM64|TRIM64B|TRIM64C|TRIM66|TRIM68|TRIM77|TRMT112|TRPC6|TRPM5|TRPT1|TSG101|TSGA10IP|TSKU|TSPAN18|TSPAN32|TSPAN4|TSSC4|TTC12|TTC17|TTC36|TTC9C|TUB|TUT1|TYR|UBASH3B|UBE2L6|UBE4A|UBQLN3|UBQLNL|UBTFL1|UBXN1|UCP2|UCP3|UEVLD|UNC93B1|UPK2|UQCC3|USH1C|USP2|USP28|USP35|USP47|UVRAG|VEGFB|VPS11|VPS26B|VPS37C|VPS51|VSIG2|VSTM5|VWA5A|VWCE|WDR74|WEE1|WNT11|WT1|WT1-AS|XRRA1|YAP1|YIF1A|YPEL4|ZBED5|ZBTB16|ZBTB3|ZBTB44|ZC3H12C|ZDHHC13|ZDHHC24|ZDHHC5|ZFP91|ZFPL1|ZFTA|ZNF143|ZNF195|ZNF202|ZNF214|ZNF215|ZNF408|ZNF705E|ZNHIT2|ZNRD2|ZP1|ZPR1|ZW10|ADM|ADAMTS8|AGBL2|AHNAK|AIP|AKIP1|ALDH3B1|ALDH3B2|ALG8|ALG9|ALKBH3|ALKBH8|ALX4|AMBRA1|AMOTL1|AMPD3|ANAPC15|ANGPTL5|ANKK1|ANKRD13D|ANKRD42|ANKRD49|ANO1|ANO3|ANO5|ANO9|AP2A2|AP5B1|APBB1|API5|APIP|APLNR|APLP2|APOA1|APOA4|APOA5|APOC3|AQP11|ARAP1|ARAP1-AS2|ARCN1|ARFGAP2|ARFIP2|ARHGAP1|ARHGAP20|ARHGAP32|ARHGAP42|ARHGEF12|ARHGEF17|ARHGEF17-AS1|ARL14EP|ARL2|ARRB1|ART1|ART5|ASCL2|ASCL3|ASRGL1|ATG13|ATG16L2|ATG2A|ATL3|ATM|ATP5MG|B3GAT1|B3GAT3|B3GNT6|B4GALNT4|B4GAT1|BACE1|BACE1-AS|BAD|BANF1|BARX2|BATF2|BBOX1|BBS1|BCL9L|BCO2|BDNF|BDNF-AS|BEST1|BIRC2|BIRC3|BLID|BMAL1|BRMS1|BRSK2|BSCL2|BSX|BTBD10|BTBD18|BTG4|BUD13|C11orf16|C11orf21|C11orf24|C11orf40|C11orf42|C11orf52|C11orf54|C11orf58|C11orf65|C11orf68|C11orf71|C11orf86|C11orf87|C11orf91|C11orf96|C1QTNF4|C1QTNF5|C2CD2L|C2CD3|CABP2|CABP4|CADM1|CALCA|CALCB|CAPN1|CAPN5|CAPRIN1|CARD16|CARD17|CARD18|CARNS1|CARS1|CASP1|CASP12|CASP4|CASP5|CAT|CATSPER1|CATSPERZ|CAVIN3|CBL|CBLIF|CCDC15|CCDC179|CCDC34|CCDC73|CCDC81|CCDC82|CCDC83|CCDC85B|CCDC86|CCDC87|CCDC88B|CCDC89|CCDC90B|CCKBR|CCND1|CCS|CD151|CD248|CD3D|CD3E|CD3G|CD44|CD5|CD59|CD6|CD81|CD82|CDC42BPG|CDC42EP2|CDCA5|CDHR5|CDK2AP2|CDKN1C|CDON|CELF1|CENATAC|CEND1|CEP126|CEP164|CEP295|CEP57|CFAP300|CFAP68|CFL1|CHEK1|CHID1|CHKA|CHORDC1|CHRDL2|CHRM1|CHRM4|CHRNA10|CHST1|CKAP5|CLCF1|CLDN25|CLMP|CLNS1A|CLP1|CLPB|CNGA4|CNIH2|CNTF|CNTN5|COA4|COMMD9|COPB1|CORO1B|COX8A|CPSF7|CPT1A|CRACR2B|CREB3L1|CREBZF|CRTAM|CRY2|CRYAB|CSKMT|CSNK2A3|CSRP3|CST6|CSTF3|CSTPP1|CTNND1|CTR9|CTSC|CTSD|CTSF|CTSW|CTTN|CUL5|CWC15|CWF19L2|CXCR5|CYB561A3|CYB5R2|CYP2R1|DAGLA|DBX1|DCDC1|DCHS1|DCPS|DCUN1D5|DDB1|DDB2|DDI1|DDIAS|DDX10|DDX25|DDX6|DEAF1|DEFB108B|DENND2B|DENND5A|DEPDC7|DEUP1|DGAT2|DGKZ|DHCR7|DIXDC1|DKK3|DLAT|DLG2|DNAJB13|DNAJC24|DNAJC4|DNHD1|DPAGT1|DPF2|DPP3|DRAP1|DRC12|DRD2|DRD4|DSCAML1|DTX4|DUSP8|DYNC2H1|E2F8|EED|EEF1G|EFEMP2|EHBP1L1|EHD1|EHF|EI24|EIF1AD|EIF3F|EIF3M|EIF4G2|ELF5|ELMOD1|ELP4|EML3|EMSY|ENDOD1|EPS8L2|ESAM|ESRRA|ETS1|EXPH5|EXT2|F2|FADD|FADS1|FADS2|FADS3|FAM111A|FAM111B|FAM118B|FAM168A|FAM180B|FAM181B|FAM76B|FAM86C1P|FAM89B|FANCF|FAR1|FAT3|FAU|FBXO3|FCHSD2|FDX1|FDXACB1|FEN1|FERMT3|FEZ1|FGF19|FGF3|FGF4|FHIP1B|FIBIN|FIBP|FJX1|FKBP2|FLI1|FLRT1|FNBP4|FOLH1|FOLH1B|FOLR1|FOLR2|FOLR3|FOSL1|FOXR1|FOXRED1|FREY1|FRMD8|FSHB|FTH1|FUT4|FXYD2|FXYD6|FXYD6-FXYD2|FZD4|GAB2|GAL|GAL3ST3|GALNT18|GANAB|GAS2|GATD1|GDPD4|GDPD5|GLB1L2|GLB1L3|GLYAT|GLYATL1|GLYATL2|GNG3|GPHA2|GPR137|GPR152|GPR83|GRAMD1B|GRIA4|GRIK4|GRK2|GRM5|GSTP1|GTF2H1|GUCY1A2|HBG1|H19|H2AX|HARBI1|HBB|HBD|HBE1|HBG2|HEPACAM|HEPHL1|HEPN1|HIKESHI|HINFP|HIPK3|HMBS|HNRNPUL2|HOATZ|HPS5|HPX|HRAS|HSD17B12|HSPA8|HSPB2|HTATIP2|HTR3A|HTR3B|HYLS1|HYOU1|IFITM1|IFITM10|IFITM2|IFITM3|IFITM5|IFT46|IFTAP|IGF2|IGF2-AS|IGHMBP2|IGSF22|IGSF9B|IL10RA|IL18|IL18BP|ILK|IMMP1L|INCENP|INPPL1|INS|INS-IGF2|INSC|INTS4|INTS5|IPO7|IRAG1|IRF7|IZUMO1R|JAM3|JAML|JHY|JRKL|KAT5|KBTBD3|KBTBD4|KCNA4|KCNC1|KCNE3|KCNJ1|KCNJ11|KCNJ5|KCNJ5-AS1|KCNK4|KCNK7|KCNQ1|KCNQ1DN|KCNQ1OT1|KCTD14|KCTD21|KDM2A|KDM4D|KDM4E|KIAA1549L|KIF18A|KIRREL3|KLC2|KLHL35|KMT2A|KMT5B|KRTAP5-1|KRTAP5-10|KRTAP5-11|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|KRTAP5-7|KRTAP5-8|KRTAP5-9|LAMTOR1|LARGE2|LAYN|LBHD1|LDHA|LDHAL6A|LDHC|LDLRAD3|LGALS12|LGR4|LIN7C|LINC00294|LINC02714|LINC02743|LINC02873|LIPT2|LMNTD2|LMNTD2-AS1|LMO1|LMO2|LOC100132686|LOC101929473|LPXN|LRFN4|LRP4|LRP5|LRRC10B|LRRC32|LRRC4C|LRRC55|LRRC56|LRRN4CL|LRTOMT|LSP1|LTBP3|LTO1|LUZP2|LYVE1|MACROD1|MADD|MADD-AS1|MAJIN|MALAT1|MAML2|MAP3K11|MAP4K2|MAP6|MAPK8IP1|MARK2|MCAM|MDK|ME3|MED17|MED19|MEN1|METTL15|MFRP|MICAL2|MICALCL|MIR100|MIR125B1|MIR130A|MIR139|MIR192|MIR194-2|MIR210|MIR210HG|MIR326|MIR34B|MIR34BHG|MIR34C|MIR610|MIRLET7A2|MMP1|MMP10|MMP12|MMP13|MMP20|MMP26|MMP27|MMP3|MMP7|MMP8|MOB2|MOGAT2|MPEG1|MPPED2|MPZL2|MPZL3|MRE11|MRGPRD|MRGPRE|MRGPRF|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|MRGPRX4|MRPL11|MRPL16|MRPL17|MRPL21|MRPL23|MRPL48|MRPL49|MS4A1|MS4A10|MS4A12|MS4A13|MS4A14|MS4A15|MS4A18|MS4A2|MS4A3|MS4A4A|MS4A4E|MS4A5|MS4A6A|MS4A6E|MS4A7|MS4A8|MSANTD2|MSANTD4|MTA2|MTCH2|MTMR2|MTNR1B|MTRNR2L8|MUC15|MUC2|MUC5AC|MUC5B|MUC6|MUS81|MYBPC3|MYEOV|MYO7A|MYOD1|MYRF|NAA40|NAALAD2|NAALADL1|NADSYN1|NAP1L4|NARS2|NAT10|NAV2|NCAM1|NCAPD3|NCR3LG1|NDUFC2|NDUFC2-KCTD14|NDUFS3|NDUFS8|NDUFV1|NDUFV1-DT|NEAT1|NECTIN1|NELL1|NEU3|NFRKB|NHERF4|NKAPD1|NLRP10|NLRP14|NLRP6|NLRX1|NNMT|NOX4|NPAS4|NPAT|NR1H3|NRGN|NRIP3|NRXN2|NTM|NUCB2|NUDT22|NUDT8|NUMA1|NUP160|NUP98|NXF1|NXPE1|NXPE2|NXPE4|OAF|OLFML1|OMP|OOSP2|OPCML|OR10A2|OR10A3|OR10A4|OR10A5|OR10A6|OR10AG1|OR10G4|OR10G7|OR10G8|OR10G9|OR10Q1|OR10S1|OR10V1|OR10W1|OR1S1|OR1S2|OR2AG1|OR2AG2|OR2AT4|OR2D2|OR2D3|OR4A15|OR4A16|OR4A47|OR4A5|OR4B1|OR4C11|OR4C12|OR4C13|OR4C15|OR4C16|OR4C3|OR4C46|OR4C6|OR4D10|OR4D11|OR4D5|OR4D6|OR4D9|OR4P4|OR4S1|OR4S2|OR4X1|OR4X2|OR51A2|OR51A4|OR51A7|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|OR51I2|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52E2|OR52E4|OR52E6|OR52E8|OR52H1|OR52I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR52N2|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OR56B1|OR56B4|OR5A1|OR5A2|OR5AK2|OR5AN1|OR5AP2|OR5AR1|OR5AS1|OR5B12|OR5B17|OR5B2|OR5B21|OR5B3|OR5D13|OR5D14|OR5D16|OR5D18|OR5F1|OR5I1|OR5J2|OR5L1|OR5L2|OR5M1|OR5M10|OR5M11|OR5M3|OR5M8|OR5M9|OR5P2|OR5P3|OR5T1|OR5T2|OR5T3|OR5W2|OR6A2|OR6M1|OR6Q1|OR6T1|OR6X1|OR8A1|OR8B12|OR8B2|OR8B3|OR8B4|OR8B8|OR8D1|OR8D2|OR8D4|OR8G1|OR8G5|OR8H1|OR8H2|OR8H3|OR8I2|OR8J1|OR8J3|OR8K1|OR8K3|OR8K5|OR8U1|OR8U3|OR9G1|OR9G4|OR9I1|OR9Q1|OR9Q2|OSBP|OSBPL5|OTOG|OTUB1|OVCH2|OVOL1|P2RX3|P2RY2|P2RY6|P4HA3|PAAF1|PACS1|PACSIN3|PAFAH1B2|PAK1|PAMR1|PANX1|PANX3|PARVA|PATE1|PATE2|PATE3|PATE4|PATL1|PAX6|PC|PCF11|PCNX3|PCSK7|PDE2A|PDE3B|PDGFD|PDHX|PELI3|PEX16|PGA3|PGA4|PGA5|PGAP2|PGGHG|PGM2L1|PGR|PHF21A|PHLDA2|PHLDB1|PHOX2A|PHRF1|PICALM|PIDD1|PIH1D2|PIK3C2A|PITPNM1|PIWIL4|PKNOX2|PKP3|PLAAT2|PLAAT3|PLAAT4|PLAAT5|PLCB3|PLEKHA7|PLEKHB1|PLET1|PNPLA2|POGLUT3|POLA2|POLD3|POLD4|POLR2G|POLR2L|POU2AF1|POU2AF2|POU2AF3|POU2F3|PPFIA1|PPFIBP2|PPME1|PPP1CA|PPP1R14B|PPP2R1B|PPP2R5B|PPP6R3|PRCP|PRDM10|PRDM11|PRDX5|PRG2|PRG3|PRMT3|PRPF19|PRR5L|PRRG4|PRSS23|PSMA1|PSMC3|PSMD13|PTDSS2|PTGDR2|PTH|PTPMT1|PTPN5|PTPRCAP|PTPRJ|PTS|PUS3|PYGM|QSER1|RAB1B|RAB30|RAB38|RAB39A|RAB3IL1|RAB6A|RAD9A|RAG1|RAG2|RAPSN|RASGRP2|RASSF10|RASSF7|RBM14|RBM14-RBM4|RBM4|RBM4B|RBM7|RBMXL2|RCE1|RCN1|RCOR2|RDX|RELA|RELT|REXO2|RHOD|RHOG|RIC3|RIN1|RNASEH2C|RNF121|RNF141|RNF169|RNF214|RNF26|RNH1|ROBO3|ROBO4|ROM1|RPL27A|RPLP2|RPS13|RPS25|RPS3|RPS6KA4|RPS6KB2|RPUSD4|RRAS2|RRM1|RRP8|RSF1|RTN3|RTN4RL2|SAA1|SAA2|SAA2-SAA4|SAA4|SAAL1|SAC3D1|SART1|SAXO4|SBF2|SC5D|SCGB1A1|SCGB1D1|SCGB1D2|SCGB1D4|SCGB2A1|SCGB2A2|SCN2B|SCN3B|SCN4B|SCT|SCUBE2|SCYL1|SDHAF2|SDHD|SELENOH|SERGEF|SERPING1|SERPINH1|SESN3|SF1|SF3B2|SHANK2|SIAE|SIDT2|SIGIRR|SIK2|SIK3|SIPA1|SIRT3|SLC15A3|SLC17A6|SLC1A2|SLC22A10|SLC22A11|SLC22A12|SLC22A18|SLC22A18AS|SLC22A24|SLC22A25|SLC22A6|SLC22A8|SLC22A9|SLC25A22|SLC25A45|SLC29A2|SLC35C1		See cases	VCV000441903	11	230616 - 134938470			441903	435565			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 11p15.5-14.3(chr11:230615-25584362)x3	ASCL3|CEND1|CHID1|EIF3F|EIF4G2|EPS8L2|FANCF|LDHAL6A|MRGPRX4|MRPL17|OR10A2|OR51E2|OR51F1|OR52E2|OR52E4|OR52E6|OR56A4|OR56A5|PTPN5|RASSF10|SERGEF|SIGIRR|TRIM34|ZNF195|TRIM5|TSG101|TSPAN32|TSPAN4|TSSC4|TRIM68|TRPM5|TUB|UBQLN3|UBQLNL|UEVLD|TRIM6|TRIM66|ZNF214|ZNF215|SIRT3|SLC17A6|TMEM9B|SWAP70|SYT8|RRAS2|RRM1|RRP8|SAA1|SAA2|RHOG|RIC3|SYT9|TAF10|TALDO1|TEAD1|TH|TIMM10B|TNNI2|TNNT3|TMEM41B|TMEM80|TMEM86A|OR56B1|OR56B4|OR5P2|OR5P3|OR6A2|OSBPL5|OVCH2|PARVA|PDE3B|PGAP2|PGGHG|PNPLA2|POLR2L|OTOG|RASSF7|RPL27A|RPLP2|RPS13|RBMXL2|RNF141|RNH1|OR52E8|OR52H1|OR52I1|OR51I2|OR51L1|OR51M1|OR51T1|OR51V1|OR51I1|OR52I2|OR52J3|OR52K1|OR52K2|OR52L1|OR52M1|OR52N1|OR10A3|OR2AG1|OR2AG2|OR2D3|OR51A2|OR10A4|OR10A5|OR10A6|OR2D2|MUC2|MUC5AC|OR51A4|OR51A7|OR52N2|OR51F2|OR51Q1|OR51S1|OR51G1|OR51G2|MRPL23|LMNTD2-AS1|LMO1|LRRC56|LSP1|LUZP2|LYVE1|MICAL2|MICALCL|MIR210|MIR210HG|MMP26|MUC5B|MUC6|MTRNR2L8|MYOD1|IFITM5|INSC|NAP1L4|NAV2|NCR3LG1|NELL1|NLRP10|LDHC|LMNTD2|GATD1|DEAF1|COPB1|CRACR2B|CSNK2A3|CTSD|CYB5R2|CYP2R1|DBX1|DCHS1|DENND2B|GTF2H1|FAR1|FHIP1B|GALNT18|GAS2|B4GALNT4|BMAL1|C11orf16|C11orf21|HPS5|HPX|BRSK2|C11orf40|C11orf42|C11orf58|CALCA|CALCB|AMPD3|ANO5|ANO9|CARS1|CAVIN3|BTBD10|CHRNA10|CNGA4|CSRP3|CTR9|ABCC8|ADM|AKIP1|AP2A2|APBB1|ARFIP2|ART1|ART5|ASCL2|CCDC179|CCKBR|CD151|CD81|CDHR5|CDKN1C|DENND5A|DKK3|DNHD1|DRD4|DUSP8|E2F8|H19|HBB|HBD|HBE1|HBG1|HBG2|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|IGSF22|ILK|INS|INS-IGF2|IPO7|IRAG1|IRF7|KCNC1|KCNJ11|LDHA|KCNQ1|KCNQ1DN|KCNQ1OT1|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|MOB2|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MRGPRX3|NLRP14|NLRP6|NRIP3|NUCB2|NUP98|OLFML1|OR51B2|OR51B4|OR51B5|OR51B6|OR51D1|OR51E1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52D1|OR52N4|OR52N5|OR52R1|OR52W1|OR56A1|OR56A3|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PPFIBP2|PRMT3|PSMA1|PSMD13|PTDSS2|PTH|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SLC22A18|SLC22A18AS|SLC25A22|SLC6A5|SMPD1|SNORA3B|SOX6|SPON1|SPTY2D1|STIM1|STK33|SVIP|TOLLIP|TPH1|TPP1|TRIM21|TRIM22|TRIM3|USH1C|USP47|WEE1|ZBED5|ZDHHC13|ZNF143		See cases	VCV000441787	11	230615 - 25584362			441787	435449			copy number gain		Pathogenic	Dec 31, 2014	no assertion criteria provided							
GRCh37/hg19 11p15.5-12(chr11:230615-37698540)x3	ART5|CCDC34|CCDC73|DNAJC24|HBG2|HIPK3|LUZP2|LYVE1|MUC2|OR51A4|OR51A7|OR51B2|OR52D1|OR52E2|OR52E4|OR56B1|OR56B4|RBMXL2|RCN1|SERGEF|TH|TIMM10B|TMEM41B|TMEM80|TMEM86A|TSPAN4|TSSC4|TUB|UBQLN3|UBQLNL|USH1C|USP47|WEE1|ZNF214|ZNF215|TRIM3|TRIM34|TRIM44|TRIM5|TMEM9B|TNNI2|UEVLD|TRIM22|TNNT3|SPON1|SPTY2D1|STIM1|STK33|SVIP|SWAP70|SLC17A6|SLC1A2|TOLLIP|TPH1|TPP1|TRAF6|TRIM21|RRAS2|RRM1|RRP8|RIC3|RPL27A|RPLP2|RPS13|SAA1|SAA2|RNF141|RNH1|SIGIRR|SIRT3|OR5P2|OR5P3|OR6A2|PRRG4|PSMA1|PSMD13|POLR2L|PPFIBP2|PRMT3|PRR5L|PTDSS2|PTH|SNORA3B|SOX6|RHOG|OR52E6|OR52E8|OR52H1|OR52J3|OR52K1|OR52N2|OR52N4|OR52N5|OR51L1|OR51M1|OR51Q1|OR51S1|OR51T1|OR52K2|OR52L1|OR52M1|OR52N1|OR52I1|OR52I2|OR51B4|OR51B5|OR51I2|OR51B6|OR51D1|OR51E1|NUP98|OLFML1|OR10A2|OR10A3|OR10A4|OR10A5|NELL1|NLRP10|OR51E2|OR51F1|OR51F2|OR51G1|OR51G2|OR51I1|MUC5AC|MOB2|MPPED2|MICAL2|MICALCL|MRGPRE|MRGPRG|MRGPRX1|MRGPRX2|MIR610|MMP26|MUC5B|NLRP14|NLRP6|HPS5|HPX|LIN7C|LINC00294|IFITM5|IFTAP|KCNC1|KCNJ11|KCNQ1|KCNQ1DN|LDHAL6A|LDHC|LDLRAD3|LGR4|NRIP3|NUCB2|METTL15|DNHD1|DRD4|ELF5|ELP4|EPS8L2|FANCF|FAR1|FBXO3|FHIP1B|FIBIN|CSTF3|FJX1|FSHB|GALNT18|GAS2|GATD1|MIR210|MIR210HG|CCKBR|CD151|CD81|CD44|CD59|CDHR5|BDNF|BDNF-AS|BMAL1|BRSK2|C11orf21|C11orf40|C11orf42|COPB1|CRACR2B|CSNK2A3|CSRP3|ASCL2|ASCL3|B4GALNT4|BBOX1|BTBD10|C11orf16|C11orf58|C11orf91|CALCA|ABCC8|ABTB2|ADM|AKIP1|AMPD3|ANO3|ANO5|ANO9|AP2A2|APBB1|APIP|ARFIP2|ARL14EP|ART1|CALCB|CAPRIN1|CARS1|CAT|CAVIN3|CCDC179|CDKN1C|CEND1|CHID1|CHRNA10|CNGA4|COMMD9|CTR9|CTSD|CYB5R2|CYP2R1|DBX1|DCDC1|DCHS1|DEAF1|DENND2B|DENND5A|DEPDC7|DKK3|DUSP8|E2F8|EHF|EIF3F|EIF3M|EIF4G2|GTF2H1|H19|HBB|HBD|HBE1|HBG1|HRAS|HTATIP2|IFITM1|IFITM10|IFITM2|IFITM3|IGF2|IGF2-AS|IGSF22|ILK|IMMP1L|KCNA4|INS|INS-IGF2|INSC|IPO7|IRAG1|IRF7|KCNQ1OT1|KIAA1549L|KIF18A|KRTAP5-1|KRTAP5-2|KRTAP5-3|KRTAP5-4|KRTAP5-5|KRTAP5-6|LDHA|LMNTD2|LMNTD2-AS1|LMO1|LMO2|LRRC56|LSP1|MRGPRX3|MRGPRX4|MRPL17|MRPL23|MTRNR2L8|MUC15|MUC6|MYOD1|NAP1L4|NAT10|NAV2|NCR3LG1|OR10A6|OR2AG1|OR2AG2|OR2D2|OR2D3|OR51A2|OR51V1|OR52A1|OR52A5|OR52B2|OR52B4|OR52B6|OR52R1|OR52W1|OR56A1|OR56A3|OR56A4|OR56A5|OSBPL5|OTOG|OVCH2|PAMR1|PARVA|PNPLA2|PAX6|PDE3B|PDHX|PGAP2|PGGHG|PHLDA2|PHRF1|PIDD1|PIK3C2A|PKP3|PLEKHA7|PTPN5|QSER1|RAG1|RAG2|RASSF10|RASSF7|SAA2-SAA4|SAA4|SAAL1|SBF2|SCT|SCUBE2|SLC22A18|SLC22A18AS|SLC25A22|SLC5A12|SLC6A5|SMPD1|SYT8|SYT9|TAF10|TALDO1|TCP11L1|TEAD1|TRIM6|TRIM66|TRIM68|TRPM5|TSG101|TSPAN32|WT1|WT1-AS|ZBED5|ZDHHC13|ZNF143|ZNF195		See cases	VCV000441715	11	230615 - 37698540			441715	435377			copy number gain		Pathogenic	Jun 23, 2014	no assertion criteria provided							
